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Cyclic structures are encountered in the core of most bioactive 
synthetic and natural products. Carbo- and heterocyclic rings give 
rigidity to molecules, allowing the fixation of functional groups in 
the space. As a result, specific interactions with biomolecules 
without important entropy costs become possible. Nitrogen-based 
functional groups are especially important in synthetic and 
medicinal chemistry. In this respect, cyclopentylamines constitute 
an important subclass of cyclic structures, present in both relatively 
simple natural products, such as the antibiotic and antiviral 
aristeromycin (1),[1] or in dauntingly complex polycyclic structures, 
such as palau’amine (2), one of the most sought for targets in 
modern organic chemistry (Figure 1).[2] They are also part of purely 
synthetic drugs. For example, ramipril (3), an angiotensin-
converting enzyme (ACE) inhibitor, was one of the top 100 generic 
drugs in 2008 for the treatment of high blood pressure and heart 
failure.[3] Consequently, the development of new synthetic 
procedures to access polysubstituted cyclopentyl amines is an 
important task for organic chemists.[4] 
 
Figure 1. Cyclopentyl Amines in Natural and Synthetic Products. 
One of the most efficient ways to access 5-membered rings is by 
concerted cycloaddition reactions or related stepwise annulation 
processes. In particular, the formal [3+2] cycloaddition, more 
correctly called [3+2] annulation, of donor-acceptor activated 
cyclopropanes[5] with alkenes or alkynes,[6] carbonyls[7] and imines[8] 
has been highly successful in the last decades for the synthesis of 
cyclopentanes/enes, tetrahydrofurans and pyrrolidines respectively. 
Cyclopropanes bearing electron-donating oxygen or aromatic 
substituents have been especially useful in Lewis or Brønsted acid-
catalyzed reactions. In contrast, annulation reactions of 
aminocyclopropanes have been limited to radical-initiated ring 
opening involving electron-rich amines.[9] To the best of our 
knowledge, no catalytic  [3+2] annulation of aminocyclopropanes 
has ever been reported. Donor-acceptor aminocyclopropanes have 
been mostly used as 1,4-imino carbonyl precursors,[10] as well as in 
a few rare ring-opening reactions.[11] In 2010, we applied them in an 
efficient formal homo-Nazarov cyclization for the synthesis of 
natural alkaloids.[12] However, a formal cycloaddition approach 
would be inherently more convergent and efficient to access 
molecular complexity. Herein, we would like to report phthalimide-
substituted acceptor cyclopropanes as unique partners in  [3+2] 
annulation reactions with silyl and alkyl enol ethers (Scheme 1). 
High yields and diastereo-selectivities were obtained using SnCl4 as 
catalyst with a broad range of enol ethers as substrates. The reaction 
was stereospecific in relation to the configuration of the enol ether 
and enantiospecific, giving an asymmetric access to chiral 
cyclopentylamines. Finally, the use of In(OTf)3 as catalyst gave 
access to important acyclic -amino ketones and deprotection of the 
phthalimide group, as well as further functionalization, was possible 
under mild conditions.  
 
Scheme 1. Lewis Acid (LA)-catalyzed reactions of 
aminocyclopropanes with enol ethers. PhthN = Phthalimide 
As a model system to study the annulation reaction with several 
aminocyclopropanes 4a-f, stable enol silyl 5a was chosen as an 
electron-rich alkene, as it was expected to have a higher reactivity 
than non-activated alkenes and should also allow a good control 
over the regioselectivity (Table 1). We started with SnCl4 as Lewis 
acid in dichloromethane, as these conditions had been successful in 
the case of oxygen-substituted cyclopropanes.[6f] However, no 
reaction was observed with cyclopropanes 4a, 4b and 4c bearing a 
Cbz protected amine, a lactam or an oxazolidinone substituent 
respectively (entries 1-3). At this point, we attempted to enhance the 
reactivity of lactam- and oxazolidinone-substituted cyclopropanes 
by the introduction of a second ester group.[6d,6h,7c-e] However, the 
obtained cyclopropanes were unstable and already decomposed 
during purification. These results further emphasized how difficult it 
is to modulate the reactivity of aminocyclopropanes when compared 
with other donor-acceptor cyclopropanes. In order to decrease the 
electron-donor ability of the nitrogen group, 
phthalimidecyclopropane 4d was investigated next (entry 4). For the 
first time, a clean annulation was observed, giving exclusively the 
trans diastereoisomer 6da of the desired cyclopentylamine![13] 
Importantly, phthalimide-substituted cyclopropanes can be obtained 
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in a single step on a multi-gram scale from commercially available 
N-vinylphthalimide and diazomalonates by Rh-catalyzed 
cyclopropanation.[14] On the other hand, removal of one of the ester 
groups led again to an unreactive cyclopropane (4e, entry 5). The 
use of SnCl4 at room temperature led to partial ring opening (entry 
6). At this point, several other Lewis acids successful in related 
[3+2] annulations[6-8] were examined (entries 7-12). Immediately, 
the exceptional reactivity of cyclopropane 4d became apparent, as 
full conversion could be obtained with a broad range of Lewis 
acids.[15] Nevertheless, a mixture of cyclization and homo-aldol 
products was obtained in most cases, with the exception of In(OTf)3 
(entry 11) and HNTf2 (entry 12), which led to complete ring opening. 
Finally, full conversion to a single diastereoisomer was also 
obtained with dimethyl ester 4f (entry 13) and the cyclopentylamine 
could be obtained in 95% isolated yield after column 
chromatography in this case.  
Table 1. Optimization of the  [3+2] Annulation. 
 
entry R1/R2 X 
Catalyst, 
Conditions[a] 
Conversion[b] 
ratio 
6:7[c] 
1 CO2Et/H  
(4a) 
SnCl4, -78 °C 0% - 
2 CO2Et/H  
(4b) 
SnCl4, -78 °C 0% - 
3 CO2Et/H  
(4c) 
SnCl4, -78 °C 0% - 
4 CO2Et/CO2Et NPhth, (4d) SnCl4, -78 °C 100% (98%)
[d] >20:1 
5 CO2Et/H  NPhth, (4e) SnCl4, -78 °C 0% - 
6 CO2Et/CO2Et NPhth, (4d) SnCl4, rt 100% 1:1 
7 CO2Et/CO2Et NPhth, (4d) Cu(OTf)2, rt 100% 5:1 
8 CO2Et/CO2Et  NPhth, (4d) Yb(OTf)2, rt 100% 5:1 
9 CO2Et/CO2Et  NPhth, (4d) Sn(OTf)2, rt 100% 2:1 
10 CO2Et/CO2Et NPhth, (4d) Sc(OTf)3, rt 100% 1:3 
11 CO2Et/CO2Et NPhth, (4d) In(OTf)3, rt 100% <1:20 
12 CO2Et/CO2Et NPhth, (4d) HNTf2, rt 100% <1:20 
13 CO2Me/CO2Me NPhth, (4f) SnCl4, -78 °C 100% (95%)
[d] >20:1 
[a] Reaction conditions: 0.040 mmol 4, 0.060 mmol 5a, 0.008 mmol 
catalyst, 0.5 mL CH2Cl2, 1 h. [b] Conversion of 4 determined by 
1H-
NMR. [c] Determined by 1H-NMR in the crude mixture. [d] Isolated 
yield after column chromatography on 0.30 mmol scale. 
When considering the importance of cyclopentylamines, and the 
lack of general methods for their synthesis, we decided to 
investigate first the scope of the cycloaddition reaction using SnCl4 
as catalyst with cyclopropane 4f (Table 2).[16] The size of the silyl 
group on the enol ether had no influence on yield or selectivity and 
the desired product was obtained in quantitative yield with very high 
diastereoselectivity (entries 1-3).[17] Both electron-donating and 
electron-withdrawing groups in para or ortho position were well 
tolerated on enol ethers derived from acetophenone (entries 4-9).  
Table 2. Scope of the [3+2] Annulation. 
entry olefin product yield, dr[a] 
 
 
 
 
1 R1=TIPS, R2=H:    5a R1=TIPS, R2=H:    6fa         95%, >20:1 
2 R1=TBS, R2=H:    5b R1=TBS, R2=H:    6fb 98%, >20:1 
3 R1=TMS, R2=H:    5c R1=TMS, R2=H:    6fc 95%, >20:1 
4 R1=TIPS, R2=F:    5d R1=TIPS, R2=F:    6fd 91%, >20:1 
5 R1=TIPS, R2=CO2Me: 5e R
1=TIPS, R2=CO2Me:6fe 95%, >20:1 
6 R1=TIPS, R2=CN: 5f R1=TIPS, R2=CN:6ff 70%, >20:1 
7 R1=TIPS, R2=OMe: 5g R1=TIPS, R2=OMe:6fg 99%, >20:1 
8 
     5h 
 6fh 
92%, >20:1 
9 
  5i 
   6fi 
91%, >20:1 
10 
       5j 
   6fj 
92%, 20:1 
11 
    5k 
  6fk 
91%, 10:1 
12 
     5l 
    6fl 
81%, 4:1 
13 
       5m 
     6fm 
96%, 17:1 
(60%)[b] 
14 
      5n     6fn 
96%, 
11:4:1 
15 
      5o 
   6fo 
90%, 4:1 
16 
             5p 
    6fp 
77%, 20:1 
17 
 
            5q 
  6fq 
99%, 20:1 
18 
 
         5r 
6fr 
99%, 1.7:1 
[a] Reaction conditions: 0.45 mmol 5, 0.30 mmol 4f, 0.015 mmol 
SnCl4, in 2 mL CH2Cl2, 1 h, -78°C. [b] Yield of major product 
determined by 1H NMR. Contaminated by other regioisomers.  
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The yields were quantitative, except in the case of a 
cyanophenyl-substituted enol ether 5f, which led to a slow reaction 
with incomplete conversion (entry 6). The reaction was 
stereospecific with Z enol ether 5j giving a highly substituted 
cyclopentylamine 6fj with perfect diastereoselectivity (entry 10). 
Interestingly, the opposite diastereoisomer with the nitrogen and the 
oxygen in a syn relationship was obtained using the enol ether 5k 
derived from tetralone (entry 11). Trisubstituted enol ether 5l could 
also be used, giving a sterically congested product with two all-
carbon N-substituted quaternary centers and one tertiary silyloxy 
group next to each other (entry 12). We then turned to silyl enol 
ethers derived from aliphatic ketones (entries 13-15). Gratifyingly, 
these substrates also worked very well in the annulation reaction, 
but the difficulties in obtaining distereomerically pure regioisomers 
of the enol ethers led to product mixtures in case of acyclic 
substrates (entry 13-14). The diastereoselectivity was moderate only 
in the case of cyclic enol ether 5o (entry 15). The commercially 
available silyl enol ether 5p derived from acetaldehyde gave the 
secondary alcohol product also with high diastereoselectivity, 
demonstrating that the reaction was not limited to enol ethers 
derived from ketones (entry 16). Finally, alkyl enol ethers could also 
be used (entries 17-18). Good diastereoselectivity was obtained in 
the case of acyclic substrate 5q (entry 17), but cyclic substrate 5r 
gave no selectivity in the annulation reaction (entry 18). Taken 
together, these results emphasize the exceptional properties of 
cyclopropane 4f in [3+2] annulation reactions with enol ethers. Most 
reported methods with other classes of donor-acceptor 
cyclopropanes for annulation with alkenes led to lower yields and 
diastereoselectivities or a limited scope.[6] 
When considering previous works on annulation reactions of 
donor-acceptor cyclopropanes,[7c] two mechanisms could be 
envisaged for the first step of the annulation: either as stepwise 
process involving ring-opening of the cyclopropane to form a 
zwitterionic intermediate followed by attack of the enol ether, or a 
process via an “intimate ion pair “[7d] involving a concerted attack of 
the enol ether anti to the malonates.[18] When using an enantiopure 
aminocyclopropane, racemization would be expected in the former 
case, whereas the latter would lead to an enantiospecific reaction. In 
the event, when enantiopure aminocyclopropane 4f was used,[19] an  
enantiospecific reaction was observed with all substrates except in 
the formation of 6fh (Scheme 2), giving access to enantiopure 
cyclopentylamines. 
 
Scheme 2. Enantiospecific reaction of cyclopropane 4f. 
To further establish the synthetic potential of the method, a few 
transformations of the cyclopentylamine products were examined 
(Scheme 3). Ring-opened product 7fa can be obtained in one single 
step from aminocyclopropane 4f using In(OTf)3 as catalyst, but in 
this case, a partial racemization was observed (Scheme 3, A). In 
contrast, reaction of 6fa in the presence of In(OTf)3 led to a smooth 
transformation to the acyclic -amino ketone 7fa without loss of the 
enantiopurity. Also -substituted -amino ketone 7fj can be 
obtained directly from 4f, but with only 4:1 dr (Scheme 3, B). If 
cyclopentylamine 6fj is formed prior to ring-opening, perfect syn 
diastereoselectivity is observed. As stereocontrol in the case of 
acyclic products is especially challenging, this is an important result. 
Finally, it is also possible to keep the cyclopentane ring in further 
transformations (Scheme 3, C). Deprotection of the phthalimide was 
possible under mild conditions.[20] Two isomeric 
cyclopentenylamines 9 and 10 could be obtained using either 
trimethylsilyl triflate or Krapcho decarboxylation conditions,[21] 
respectively. The obtained cyclopentenylamines are themselves 
parts of important bioactive compounds, such as the drug Abacavir, 
used in the treatment of HIV infection,[22] or can be used as 
platforms for further functionalization. 
 
Scheme 3. Transformations of the cyclopentyl amines. Reaction 
conditions: a) 5a, 20 mol % In(OTf)3, CH2Cl2, RT; b) 20 mol % 
In(OTf)3, CH2Cl2, RT; c) 5j, 20 mol % In(OTf)3, CH2Cl2, RT; d) 1,2-
diamino-ethane, iPrOH, 80 °C; e) TMSOTf, CH2Cl2, 0 °C; f) NaCl, 
DMSO, H2O, 170 °C. 
In summary, we have reported the first catalytic [3+2] 
annulation of aminocyclopropanes with enol ethers. The 
introduction of a phthalimide group on a cyclopropane diester was 
key to enable high yield and selectivity in the reaction. Quantitative 
yields and a very broad scope made the reaction highly useful for 
the synthesis of substituted cyclopentylamines, for which truly 
general synthetic methods are scarce. As the reaction is 
enantiospecific, enantiopure cyclopentylamines can be easily 
obtained. Finally, substituted -amino ketones or useful 
cyclopentenylamines can easily be obtained, either directly from the 
cyclopropane or from the cyclopentylamine products.  
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reaction could not be achieved so far. 
[21] a) A. P. Krapcho, J. F. Weimaster, J. M. Eldridge, E. G. E. Jahngen Jr., 
A. J. Lovey, W. P. Stephens, J. Org. Chem., 1978, 43, 138; For an 
alternative approach towards cyclopentenylamines starting from 
aminocyclopropanes, see: b) C. M. Williams, A. de Meijere, J. Chem. 
Soc. Perkin Trans. 1 1998, 3699. 
[22] P. S. Hervey, C. M. Perry, Drugs 2000, 60, 447. 
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General Methods 
 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless stated 
otherwise. For quantitative flash chromatography technical grade solvents were used. For flash 
chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, Et2O, 
CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under nitrogen 
atmosphere (H2O content < 30 ppm, Karl-Fischer titration). NEt3 and pyridine were distilled under 
nitrogen from KOH. All chemicals were purchased from Acros, Aldrich, Fluka, VWR, Aplichem or 
Merck and used as such unless stated otherwise. Chromatographic purification was performed as flash 
chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 
0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC glass plates or aluminium 
plates and visualized with UV light, permanganate stain, CAN stain or Anisaldehyde stain. Melting 
points were measured on a Büchi B-540 melting point apparatus using open glass capillaries, the data 
is uncorrected. 1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in 
chloroform-d, DMSO-d6, CD2Cl2 or CD3OD, all signals are reported in ppm with the internal 
chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm, the internal CD2Cl2 signal at 
5.31 ppm, or the internal methanol signal at 3.30 ppm as standard. The data is being reported as (s = 
singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad 
signal, coupling constant(s) in Hz, integration; interpretation). 13C-NMR spectra were recorded with 
1H-decoupling on a Brucker DPX-400 100 MHz spectrometer in chloroform-d, DMSO-d6, CD2Cl2 or 
CD3OD, all signals are reported in ppm with the internal chloroform signal at 77.0 ppm, the internal 
DMSO signal at 39.5 ppm, the internal CD2Cl2 signal at 53.5 ppm or the internal methanol signal at 
49.0 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer 
with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m = medium, s = 
strong, sh = shoulder). Gas chromatographic and low resolution mass spectrometric measurements 
were performed on a Perkin-Elmer Clarus 600 gas chromatographer and mass spectrometer using a 
Perkin-Elmer Elite fused silica column (length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. 
High resolution mass spectrometric measurements were performed by the mass spectrometry service 
of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurement were done on 
a JASCO HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector and a 
SEDEX 85 (SEDERE) detector using a CHIRALPAK IC, IB or IA column from DAICEL Chemical 
Industries Ltd. HPLC grade solvents from Sigma-Aldrich were used. 
1-Phenyl-1-trimethylsiloxyethylene (5c) was purchased from Alfa Aesar [13735-81-4] 
Vinyloxytrimethylsilane (5p) was purchased from Alfa Aesar [6213-94-1] 
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Preparation of Substrates 
Synthesis of aminocyclopropane 
 
Tosyl azide (11): 
 
Following a reported procedure1, a solution of sodium azide (10.3 g, 157 mmol, 1.5 eq) in water (60 
ml) was added dropwise over 1 h to a solution of tosyl chloride (20 g, 0.11 mol, 1 eq) in acetone (200 
ml) at 0°C. The reaction was allowed to warm up to 23°C and stirred for 16 h. The acetone was 
removed under reduced pressure at 25 °C and the reaction mixture was extracted with ether (2x 100 
ml). The combined organic layers were washed with water (2 x 100 ml) , 5% Na2CO3 (2 x 100 ml) and 
water (2 x 100 ml), dried over MgSO4 and the solvent was removed under reduced pressure to afford 
tosyl azide (20.7 g, 107 mmol, quantitative) as a colorless oil which solidify under storage at 4°C. 
 
1H NMR (400 MHz, CDCl3) δ: 7.87 (d, J = 8.4 Hz, 2 H, Ar H), 7.43 (d, J = 8.4 Hz, 2 H, Ar H), 2.51 
(s, 3 H, CH3). 
The characterization data for 11 corresponded to the reported values1 
 
Dimethyl 2-diazomalonate (12): 
 
  
 
Following a reported procedure2, dimethylmalonate (7.93 mL, 69.7 mmol, 1 eq), triethylamine (10.6 
mL, 76.6 mmol, 1.1 eq) and tosyl azide (15.1 g, 76.6 mmol, 1.1 eq) were dissolved in acetonitrile (100 
mL). The solution was stirred at 23°C for 20 h. The solution was concentrated under reduced pressure 
and partitioned between dichloromethane and water. The layers were separated and the aqueous layer 
was extracted with DCM (x1). The organic layers were combined and dried over MgSO4. The crude 
was first filtered over a plug of silica gel (PET/Et2O 1/1) to remove most of the tosylamide formed 
during the reaction. Then, purification by column chromatography (PET/Et2O 1/1) afforded dimethyl 
2-diazomalonate (10.4 g, 65.5 mmol, 94%) as a yellow oil which solidified under storage at 4°C. 
 
Rf (PET/Et2O 1/1) = 0.32. 
1H NMR (400 MHz, CDCl3) δ: 3.87 (s, 1 H). 
13C NMR (101 MHz, CDCl3) δ 161.2, 52.43 
The characterization data for 12 corresponded to the reported values2 
 
  
                                                          
1 P. R. Serwinski, B. Esat, P. M. Lahti, Y. Liao, R. Walton, J. Lan, J. Org. Chem. 2004, 69, 5247 
2 P. Wyatt, A. Hudson,  J. Charmant, A. G. Orpen, H. Phetmung, Org. Biomol. Chem. 2006, 4, 2218 
3 The diazo carbon could not be detected 
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Diethyl 2-diazomalonate (13): 
 
  
Following the procedure described below, diethylmalonate (2.17 mL, 14.3 mmol, 1 eq), triethylamine 
(2.18 mL, 15.7 mmol, 1.1 eq) and tosyl azide (3.09 g, 15.7 mmol, 1.1 eq) were dissolved in 
acetonitrile (20 mL). The solution was stirred at 23°C for 20 h. The solution was concentrated under 
reduced pressure and partitioned between DCM and water. The layers were separated and the aqueous 
layer was extracted with dichloromethane (x1). The organic layers were combined and dried over 
MgSO4. The crude was first filtered over a plug of silica gel (PET/Et2O 1/1) to remove most of the 
tosylamide formed during the reaction. Then, purification by column chromatography (PET/Et2O 1/1) 
afforded dimethyl 2-diazomalonate (2.3 g, 12 mmol, 86%) as a yellow oil which solidified under 
storage at 4°C. 
Rf (PET/Et2O 1/1) = 0.48. 
1H NMR (400 MHz, CDCl3) δ 4.27 (q, 4 H, J = 7.1 Hz), 1.28 (t, 6 H, J = 7.1 Hz). 
13C NMR (101 MHz, CDCl3) δ 161.0, 61.5, 14.33 
The characterization data for 13 corresponded to the reported values4 
 
Cyclopropanes 4 a-f 
 
 
 
Rhodium catalyzed cyclopropanation: 
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4f): 
 
 
 
Following a modified procedure5, bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] 
(10.9 mg, 0.014 mmol, 0.1 mol %) is weighted in the glovebox. The flask is closed with a septum and 
put under N2 atmosphere. A solution of N-vinyl-phthalimide (2.5 g, 14 mmol, 1 eq) in 30 mL of dry 
dichloromethane is added and the resulting green suspension is cooled down to 0°C with an ice/water 
bath. A solution of dimethyl-2-diazomalonate (2.5 g, 15 mmol, 1.1 eq) in 20 mL of dichloromethane is 
added over five minutes. When the addition is complete, the reaction is allowed to warm to room 
temperature. After 5 h at room temperature, the solvent is removed under reduced pressure and the 
                                                          
4 M. Kitamura, N. Tashiro, S. Miyagawa, T. Okauchi, Synthesis, 2011, 7, 1037 
5 F. Gonzalez-Bobes, M. D. B. Fenster, S. Kiau, L. Kolla, S. Kolotuchin, M. Soumeillant, Adv. Synth. Catal. 
2008, 350, 813 
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crude is directly purified by column chromatography (9:1 Hexane/Ethyl Acetate to 7:3 Hexane/Ethyl 
Acetate). 3.40 g (11.2 mmol, 78 % yield) of 4f as a white solid was isolated.  
The two enantiomers were separated by HPLC using Chiralpack IA column (0.46x25 cm), 95:5 
Hexane/Isopropanol, 1 ml/min; tr1 = 23.9 min, [α]D25.0 122 (c = 0.69, CHCl3); tr2 = 27.1 min,  
[α]D25.0 -122 (c = 0.1, CHCl3) 
Preparative HPLC: Column IA 20x250 mm, 98:2 Hexane/Isopropanol, 16 ml/min. tr1 = 45 min, tr2 = 
75 min 
Rf 0.27 (6:4, Hexane/Ethyl acetate). 
Mp 124.6-125 °C 
1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, Phth), 7.75 (m, 2 H, Phth), 3.85 (s, 3 H, OMe), 3.72 (dd, 
1 H, J = 8.5, 6.6 Hz, N-CH), 3.64 (s, 3 H, OMe), 2.73 (dd, 1 H, J = 6.5, 6.5 Hz, CH2), 2.06 (dd, 1 
H, J = 8.5, 6.4 Hz, CH2).  
13C NMR (101 MHz, CDCl3) δ 168.5, 167.8, 166.9, 134.3, 131.4, 123.5, 53.1, 53.0, 34.9, 33.1, 19.6.  
IR 2956 (w), 1783 (w), 1727 (s), 1468 (w), 1439 (w), 1399 (m), 1329 (m), 1294 (m), 1222 (m), 1134 
(w), 909 (w), 876 (w), 720 (m).  
HRMS (ESI) calcd for C15H14NO6+ [M+H]+ 304.0816; found 304.0804. 
 
Trans-ethyl 2-(((benzyloxy)carbonyl)amino)cyclopropanecarboxylate (4a): 
 
 
 
Following the same procedure described above, using 50 mg (0.28 mmol, 1 eq) of N-Vinyl-O-benzyl 
Urethane6, 64 mg (0.56 mmol, 2 eq) of Ethyl-diazoacetate and 2.1 mg (0.0028 mmol, 1 mol %) of 
Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)]. After column chromatography 
(100% Heptane + 1% Net3 to 9:1 Heptane/Ethyl Acetate + 1% Net3) 26.7 mg (0.10 mmol, 36% yield) 
of trans-product is obtained. 
Rf 0.5 (7:3 Petroleum ether/Ethyl Acetate) 
1H NMR (400 MHz, CDCl3) δ 7.42-7.32 (m, 5 H, Ar), 5.13 (m, 2 H, Ar-CH2)), 4.16 (m, 2 H, O-CH2-
CH3, 3.12 (m, 1 H, N-C-H), 1.79 (m, 1 H, CH2), 1.45 (m, 1 H, CH2), 1.25-1.31 (t, 3 H, J= 7.5 Hz, O-
CH2-CH3), 1.14-1.19 (m, 1 H, CH2) 
The characterization data for 4a corresponded to the reported values 7 
 
Diethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (4d): 
 
 
 
Following the same procedure described above, using 3.0 g (18 mmol, 1 eq) of N-vinyl-phthalimide, 
4.0 g (21 mmol, 1.2 eq) of diethyl-2-diazomalonate and 14 mg (0.018 mmol, 0.1 mol %) of 
Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)], 5.4 g (16 mmol, 90 % yield) of a 
white solid was obtained. 
Rf 0.36 (6:4, Hexane/Ethyl acetate) 
                                                          
6 D. J. am Ende, K. M. DeVries, P. J. Clifford, and S. J. Brenek, Org. Proc. Res. Dev., 1998, 2, 382 
7 J. A. Miller,  E. J. Hennessy, W. J. Marshall, M. A. Scialdone, S. T. Nguyen,  J. Org. Chem., 2003, 68, 7884 
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Mp 93.1 °C. 
1H NMR (400 MHz, CDCl3) δ 7.85 (m, 2 H, Phth), 7.74 (m, 2 H, Phth), 4.30 (m, 2 H, OCH2), 4.07 
(m, 2 H, OCH2), 3.71 (dd, 1 H, J = 8.5, 6.6 Hz, N-C-H), 2.74 (t, 1 H, J = 6.5 Hz, CH2), 2.02 (dd, 1 H, J 
= 8.5, 6.4 Hz, CH2), 1.34 (t, 3 H, J = 7.1 Hz, CH3), 1.12 (t, 3 H, J = 7.1 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 168.2, 167.8, 166.4, 134.3, 131.6, 123.4, 62.0, 61.8, 34.7, 33.5, 19.2, 
14.1, 13.8.  
IR 2985 (w), 2938 (w), 2907 (w), 1783 (m), 1719 (s), 1614 (w), 1393 (s), 1321 (m), 1218 (s), 1133 
(m), 719 (s). 
HRMS (ESI) calcd for C17H18NO6+ [M+H]+ 332.1129; found 332.1135 
 
Copper catalyzed cyclopropanation 
 
Trans-ethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropanecarboxylate (4e): 
 
 
 
copper-(I)-trifluoromethanesulfonate-toluene complex (26.4 mg, 0.0510 mmol, 2.5 mol %) is 
weighted in the glovebox. The flask is closed with a septum, protected from light and put under N2 
atmosphere. A solution of N-vinyl-phthalimide (500 mg, 2.04 mmol, 1 eq) in 4 mL of dry 
dichloromethane is added. Ethyl diazoacetate (0.860 ml, 8.16 mmol, 4 eq) is added via a syringe pump 
over 18 h. When the addition is complete, the solvent is removed under reduced pressure and the crude 
is directly purified by column chromatograpy (8:2 Petroleum Ether/Ethyl Acetate). The isolated 
yellow solid is recrystallized in Petroleum Ether/Ethyl Acetate to give 205 mg (0.791 mmol, 40 % 
yield) of the trans cyclopropane as a colorless solid. 
Rf 0.36 (8:2, Petroleum Ether/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.87-7.81 (m, 2 H, Phth), 7.77-7.71 (m, 2 H, Phth), 4.22 (q, 2 H, J = 
7.2 Hz, O-CH2-CH3), 3.35-3.28 (m, 1 H, N-C-H), 2.25-2.20 (m, 1 H, CHCO2Et), 1.76 (dt, 1 H, J = 9.3, 
5.5 Hz, CH2), 1.65 (dt, 1 H, J = 8.1, 5.9 Hz, CH2), 1.32 (t, 3 H, J = 7.2 Hz, O-CH2-CH3). 
13C NMR (101 MHz, CDCl3) δ 172.1, 168.0, 134.3, 131.6, 123.4, 61.1, 29.5, 20.0, 14.2, 13.6 
The characterization data for 4b corresponded to the reported values8 
 
Trans-ethyl 2-(2-oxopyrrolidin-1-yl)cyclopropanecarboxylate (4b): 
 
 
 
Following the same procedure described above, using 250 mg (2.25 mmol, 1 eq) of commercially 
available N-vinyl-pyrrolidone [88-12-0], 0.95 mL (8.9 mmol, 4 eq) of ethyl diazoacetate and 29 mg 
(0.056 mmol, 2.5 mol %) of copper-(I)-trifluoromethanesulfonate-toluene complex, 240 mg (1.22 
                                                          
8 A. Abu-Elfotoh, K. Phomkeona, K. Shibatomi, S. Iwasa, Angew. Chem. Int. Ed. 2010, 49, 8439 –8443 
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mmol, 54 % yield) of a yellow oil is obtained after column chromatography purification (9/1 
Petroleum Ether/Ethyl Acetate to 100 Ethyl Acetate). 
Rf 0.2 (Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 4.15 (qd, 2 H, J = 7.2, 1.5 Hz, O-CH2-CH3), 3.31 (t, 2 H, J = 7.2 Hz, 
CH2 pyrrolidone), 3.20-3.15 (m, 1 H, N-C-H), 2.39 (t, 2 H, J = 8.0 Hz, CH2 pyrrolidone), 2.05-1.96 (m, 
2 H, CH2 pyrrolidone), 1.88-1.82 (m, 1 H, CHCO2Et), 1.51-1.38 (m, 2 H, CH2), 1.27 (t, 3 H, J = 7.1 
Hz, O-CH2-CH3).  
13C NMR (101 MHz, CDCl3) δ 175.9, 172.3, 60.9, 47.2, 34.1, 31.7, 19.7, 18.0, 14.2, 14.1. 
The characterization data for 4b corresponded to the reported values 8 
 
Ethyl 2-(2-oxooxazolidin-3-yl)cyclopropanecarboxylate (4c): 
 
 
 
Following the same procedure described above, using 2.42 g (21.4 mmol, 1 eq) of N-vinyl-
oxazolidinone9, 9.0 mL (86 mmol, 4 eq) of ethyl diazoacetate and 277 mg (0.534 mmol, 2.5 mol %) of 
copper-(I)-trifluoromethanesulfonate-toluene complex, 3.21 g (16.1 mmol, 75 % yield) of a yellow oil 
is obtained after column chromatography purification (9/1 Petroleum Ether/Ethyl Acetate to 100 Ethyl 
Acetate).  
1:1 Mixture of cis and trans non-separable diastereomers. 
Rf 0.3 (98:2 DCM/MeOH). 
1H NMR (400 MHz, CDCl3) δ 4.35-4.26 (m, 4 H, CH2 oxazolidinone), 4.19-4.11 (m, 4 H, O-CH2-
CH3), 3.74 (dd, 1 H, J = 7.9, 7.9 Hz, N-C-H), 3.60-3.50 (m, 3 H, N-C-H and CH2 oxazolidinone), 3.07-
3.00 (m, 2 H, CH2 oxazolidinone), 2.02 (m, 1 H, CHCO2Et), 1.90 (m, 1 H, CHCO2Et), 1.55 (q, 1 H, J 
= 6.0 Hz, CH2), 1.52-1.43 (m, 2 H, CH2), 1.38-1.31 (m, 1 H, CH2), 1.30-1.24 (m, 6 H, O-CH2-CH3). 
13C NMR (101 MHz, CDCl3) δ 171.9, 170.5, 158.5, 157.9, 62.3, 61.9, 61.0, 61.0, 45.7, 45.7, 34.4, 
33.0, 20.7, 20.6, 15.0, 14.2, 12.810 
IR 2986 (w), 2985 (w), 2917 (w), 1751 (s), 1723 (s), 1722 (s), 1426 (m), 1409 (m), 1185 (s), 1040 
(m). 
HRMS (ESI) calcd for C9H14NO4+ [M+H]+ 200.0917; found 200.0908 
  
                                                          
9 Prepared following the reported procedure: Org. Lett. 2004, 6, 1845 
10 One carbon aliphatic of one diastereomer could not be resolved 
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Synthesis of Silyl Enol Ethers 
 
General procedure for the synthesis of Silyl Enol Ethers: 
 
 
 
Method A: 
The ketone (1 eq) in anhydrous THF is added in an oven-dried flask sealed with a septum and under 
N2 atmosphere. The solution is cooled down to -78 °C and a 2 M solution of NaHMDS (1.22 eq) is 
added dropwise. The cold bath is removed and the pale yellow solution is stirred for 1 hour at room 
temperature. The reaction is cooled again at -78 °C and the corresponding silyl chloride (1.2 eq) is 
added dropwise. The reaction is stirred at room temperature for 5 hours after what the solvent is 
directly removed under reduced pressure. The resulting orange oil is purified by plug or by column 
chromatography  on triethylamine-deactivated silica (100 % Hexane). 
 
Method B: 
The ketone (1 eq) in anhydrous dichloromethane is added in an oven-dried flask sealed with a septum 
and under N2 atmosphere . Triethylamine (1.8 eq) and then triisopropylsilyl-trifluoromethanesulfonate 
(1.2 eq) are added at room temperature. After two hours, the reaction is diluted with dichloromethane 
and washed with a solution of sat. NH4Cl. The aqueous layer is extracted three times with ethyl 
acetate. The organic layers are collected, washed with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure. The crude oil is purified by plug or column 
chromatography  on triethylamine deactivated silica (100 % Hexane). 
 
Triisopropyl((1-phenylvinyl)oxy)silane (5a):  
 
 
 
Using method A, starting from 580 mg of acetophenone (4.82 mmol), 1.03 g (3.72 mmol, 77 % yield) 
of a colorless oil was obtained. 
1H NMR (400 MHz, CDCl3) δ 7.69-7.65 (m, 2 H, Ar), 7.38-7.29 (m, 3 H, Ar), 4.85 (d, 1 H, J = 1.8 
Hz, C=CH2), 4.41 (d, 1 H, J = 1.8 Hz, C=CH2), 1.39-1.27 (m, 3 H, SiCH(CH3)2), 1.19-1.13 (m, 18 H, 
SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 156.2, 138.0, 128.2, 128.1, 125.4, 90.0, 18.2, 12.9 
The characterization data for 5a corresponded to the reported values11 
 
  
                                                          
11 Jun-Feng Zhao, Boon-Hong Tan and Teck-Peng Loh Chem. Sci. 2011, 2, 349 
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tert-Butyldimethyl((1-phenylvinyl)oxy)silane (5b): 
 
 
 
Using method A, starting from 580 mg of acetophenone (4.82 mmol), 960 mg (4.10 mmol, 85 % 
yield) of a colorless oil was obtained. 
1H NMR (400 MHz, CDCl3) δ 7.65-7.60 (m, 2 H, Ar), 7.39-7.29 (m, 3 H, Ar), 4.89 (d, 1 H, J = 1.7 
Hz, C=CH2), 4.42 (d, 1 H, J = 1.7 Hz, C=CH2), 1.00 (s, 9 H, Si(CH3)2C(CH3)3), 0.21 (s, 5 H, 
Si(CH3)2C(CH3)3). 
13C NMR (101 MHz, CDCl3) δ 156.0, 137.8, 128.2, 128.1, 125.3, 90.9, 25.9, 18.4, -4.6.  
The characterization data for 5b corresponded to the reported values11 
 
((1-(4-Fluorophenyl)vinyl)oxy)triisopropylsilane (5d): 
 
 
 
Using method B, starting from 500 mg of 4'-Fluoroacetophenone (3.62 mmol), 776 mg (2.64 mmol, 73 
% yield) of a colorless oil were obtained. 
1H NMR (400 MHz, CDCl3) δ 7.61 (m, 2 H, Ar), 7.00 (m, 2 H, Ar), 4.77 (d, 1 H, J = 2.0 Hz, C=CH2), 
4.39 (d, 1 H, J = 1.9 Hz, C=CH2), 1.43-1.29 (m, 3 H, SiCH(CH3)2), 1.22-1.14 (m, 18 H, SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 162.8 (d, J = 248 Hz), 155.3, 134.1 (d, J = 3 Hz), 127.1 (d, J = 8.1 
Hz), 114.9 (d, J = 21.5 Hz), 89.7 (d, J = 2 Hz), 18.1, 12.8. 
The characterization data for 5d corresponded to the reported values11 
 
Methyl 4-(1-((triisopropylsilyl)oxy)vinyl)benzoate (5e): 
 
 
 
Using method B, starting from 500 mg of methyl 4-acetylbenzoate (2.81 mmol), 856 mg (2.56 mmol, 
91 % yield) of a colorless oil were obtained. 
Rf 0.5 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 8.00 (m, 2 H, Ar), 7.70 (m, 2 H, Ar), 4.96 (d, 1 H, J = 2.0 Hz, C=CH2), 
4.53 (d, 1 H, J = 2.0 Hz, C=CH2), 3.92 (s, 3 H, CO2CH3), 1.37-1.26 (m, 3 H, SiCH(CH3)2), 1.18-1.12 
(m, 18 H, SiCH(CH3)2). 
11 
 
13C NMR (101 MHz, CDCl3) δ 166.9, 155.3, 142.3, 129.6, 129.5, 125.2, 92.1, 52.1, 18.1, 12.8 
IR 3669 (w), 3522 (w), 2959 (m), 2955 (m), 2943 (m), 2867 (m), 1722 (s), 1679 (m), 1282 (s), 1113 
(s) 
HRMS (ESI) calcd for C19H31O3Si+ [M+H]+ 335.2037; found 335.2032 
 
4-(1-((Triisopropylsilyl)oxy)vinyl)benzonitrile (5f): 
 
 
 
Using method B, starting from 0.50 mg of 4-Acetylbenzonitrile (3.4 mmol), 1.0 g (3.3 mmol, 97 % 
yield) of a pale orange oil were obtained. 
Rf 0.55 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.73 (m, 2 H, Ar), 7.62 (m, 2 H, Ar), 4.96 (d, 1 H, J = 2.3 Hz, C=CH2), 
4.57 (d, 1 H, J = 2.3 Hz, C=CH2), 1.39-1.26 (m, 3 H, SiCH(CH3)2), 1.18-1.12 (m, 18 H, SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 154.5, 142.2, 132.0, 125.8, 119.0, 111.5, 92.8, 18.1, 12.7. 
IR 2946 (m), 2945 (m), 2892 (w), 2868 (m), 2229 (w), 1614 (w), 1464 (w), 1317 (s), 1302 (m), 1111 
(s), 1015 (s). 
HRMS (ESI) calcd for C18H28NOSi+ [M+H]+ 302.1935; found 302.1935.  
 
Triisopropyl((1-(4-methoxyphenyl)vinyl)oxy)silane (5g): 
 
 
 
Using method A, starting from 724 mg of 4'-methoxyacetophenone (4.82 mmol), 1.3 g (4.2 mmol, 91 
% yield) of a colorless oil were obtained. 
Rf 0.75 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.65 (m, 2 H, Ar), 6.92 (m, 2 H, Ar), 4.81 (d, 1 H, J = 1.8 Hz, C=CH2), 
4.39 (d, 1 H, J = 1.8 Hz, C=CH2), 3.86 (s, 3 H, OCH3), 1.43-1.31 (m, 3 H, SiCH(CH3)2), 1.23-1.17 (m, 
18 H, SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 159.7, 155.9, 130.7, 126.7, 113.4, 88.4, 55.2, 18.2, 12.9. 
IR 2944 (w), 2891 (w), 2867 (m), 2838 (w), 1608 (m), 1510 (s), 1464 (m), 1249 (s), 1175 (s), 1014 
(s), 734 (s).  
HRMS (ESI) calcd for C18H31O2Si+ [M+H]+ 307.2088; found 307.2076 
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((1-(2-Bromophenyl)vinyl)oxy)triisopropylsilane (5h): 
 
 
 
Using method A, starting from 0.50 ml of 2'-Bromoacetophenone (3.7 mmol), 1.15 g (3.26 mmol, 88 
% yield) of a colorless oil were obtained. 
Rf  0.80 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.60 (ddd, 1 H, J = 8.0, 1.2, 0.2 Hz, Ar), 7.46 (dd, 1H, J = 7.6, 1.8 Hz, 
Ar), 7.29 (td, 1 H, J = 7.4, 1.3 Hz, Ar), 7.16 (ddd, 1 H, J = 8.0, 7.4, 1.8 Hz, Ar), 4.63 (d, 1 H, J = 1.5 
Hz, C=CH2), 4.55 (d, 1 H, J = 1.5 Hz, C=CH2), 1.32-1.21 (m, 3H, SiCH(CH3)2), 1.16-1.11 (m, 18 H, 
SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 156.2, 140.5, 133.3, 130.3, 129.1, 126.9, 121.5, 95.4, 18.1, 12.7. 
IR 2945 (w), 2891 (w), 2866 (m), 1705 (w), 1626 (w), 1589 (w), 1466 (m), 1317 (s), 1024 (s), 883 
(m). 
HRMS (ESI) calcd for C1779BrH28OSi+ [M+H]+ 355.1087; found 355.1075 
 
Triisopropyl((1-(naphthalen-1-yl)vinyl)oxy)silane (5i): 
 
 
 
Using method B, starting from 500 mg of 1'-acetonaphthone (2.94 mmol), 865 mg (2.65 mmol, 91 % 
yield) of a colorless oil were obtained. 
Rf 0.66 (100% Hexane). 
1H NMR (400 MHz, CDCl3) δ 8.42-8.37 (m, 1 H, Ar), 7.88-7.80 (m, 2 H, Ar), 7.59-7.40 (m, 4 H, Ar), 
4.76 (d, 1 H, J = 0.8 Hz, C=CH2), 4.63 (d, 1 H, J = 0.8 Hz, C=CH2), 1.30-1.17 (m, 3 H, SiCH(CH3)2), 
1.12-1.05 (m, 18 H, SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 157.6, 137.7, 133.7, 131.0, 128.4, 128.1, 126.6, 125.9, 125.8, 125.7, 
125.0, 95.9, 18.0, 12.7. 
IR 2944 (m), 2892 (w), 2866 (m), 1626 (w), 1615 (w), 1464 (w), 1304 (s), 1016 (s), 778 (s). 
HRMS (ESI) calcd for C21H31OSi+ [M+H]+ 327.2139; found 327.2132. 
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(Z)-Triisopropyl((1-phenylprop-1-en-1-yl)oxy)silane (5j): 
 
 
 
Using method A, starting from 500 mg of propiophenone (11.2 mmol), 3.2 g (11 mmol, 98 % yield) of 
a colorless oil were obtained. 
Rf  0.85 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.53-7.47 (m, 2 H, Ar), 7.36-7.25 (m, 3 H, Ar), 5.06 (q, 1 H, J = 6.9 
Hz, C=CH2), 1.85-1.80 (d, 3 H, J = 6.9 Hz, CH3), 1.19-1.05 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 151.3, 140.4, 127.9, 127.3, 126.0, 105.2, 18.0, 13.6, 11.8. 
IR 3058 (w), 2945 (s), 2918 (m), 2867 (s), 1694 (m), 1653 (w), 1464 (m), 1325 (s), 1080 (s), 1064 (s), 
883 (s).  
HRMS (ESI) calcd for C18H31OSi+ [M+H]+ 291.2139; found 291.2145. 
 
((3,4-Dihydronaphthalen-1-yl)oxy)triisopropylsilane (5k): 
 
 
 
Using method A, starting from 540 mg of alpha-tetralone (3.69 mmol), 973 mg (3.22 mmol, 87 % 
yield) of a colorless oil were obtained. 
1H NMR (400 MHz, CDCl3) δ 7.58 (dd, J = 7.4, 1.0 Hz, Ar), 7.29-7.12 (m, 3 H, Ar), 5.18 (t, 1 H, J = 
4.6 Hz, C=CH), 2.76 (t, 2 H, J = 7.7 Hz, Ar-CH2), 2.37-2.29 (m, 2 H, Ar-CH2-CH2), 1.37-1.26 (m, 3 
H, SiCH(CH3)2), 1.19-1.13 (m, 18 H, SiCH(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 148.5, 137.2, 133.8, 127.2, 126.9, 126.2, 122.0, 103.8, 28.3, 22.3, 
18.2, 12.9.  
The characterization data for 11 corresponded to the reported values12 
 
  
                                                          
12 L. Zhang, J. Sun, S. A. Kozmin, Tetrahedron, 2006, 62, 11371 
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Triisopropyl((2-methyl-1-phenylprop-1-en-1-yl)oxy)silane (5l): 
 
 
 
Using method A, starting from 548 mg of propiophenone (3.70 mmol), 1.1 g (3.6 mmol, 98 % yield) 
of a colorless oil were obtained. 
Rf 0.85 (9:1, Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.39-7.25 (m, 5 H, Ar), 1.88 (s, 3 H, CH3), 1.63 (s, 3 H, CH3), 1.08-
0.96 (m, 21 H, TIPS) 
13C NMR (101 MHz, CDCl3) δ 144.2, 139.4, 129.5, 127.6, 127.2, 111.6, 20.0, 18.2, 17.9, 13.2  
IR 2966 (m), 2962 (m), 2960 (m), 2945 (m), 2924 (m), 2867 (m), 1671 (w), 1464 (w), 1162 (s), 832 
(s) 
HRMS (ESI) calcd for C19H33OSi+ [M+H]+ 305.2295; found 305.2308.  
 
(Hex-1-en-2-yloxy)triisopropylsilane (5m): 
 
 
 
Using method A, starting from 370 mg of 2-hexanone (3.69 mmol), 873 mg (3.40 mmol, 92 % yield) 
of a colorless oil were obtained containing a 10:1.3:0.3 mixture of the di- and Z/E trisubstituted 
isomers. 
Major Isomer:  
Rf 0.75 (9:1, Hexane/Ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 4.03 (s, 1 H, C=CH2), 4.00 (s, 1 H, C=CH2), 2.08 (m, 2 H, C-CH2), 
1.51 (m, 2 H, -CH2-), 1.37 (m, 2 H, -CH2-), 1.27-1.16 (m, 3 H, SiCH(CH3)2), 1.16-1.08 (m, 18 H, 
SiCH(CH3)2), 0.93 (t, 3 H, J = 7.3 Hz, -CH3). 
13C NMR (101 MHz, CDCl3) δ 159.9, 88.6, 36.4, 29.2, 22.3, 18.0, 14.0, 12.7. 
IR 2945 (s), 2895 (w), 2868 (s), 1674 (w), 1657 (w), 1617 (w), 1464 (m), 1272 (s), 1020 (s), 883 (s) 
HRMS (ESI) calcd for C15H33OSi+ [M+H]+ 257.2295; found 257.2308. 
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Triisopropyl(pent-2-en-3-yloxy)silane (5n): 
 
 
 
Using method A, starting from 318 mg of 3-pentanone (3.69 mmol), 549 mg (2.26 mmol, 61 % yield) 
of a colorless oil were obtained containing a 8.3:1 mixture of Z/E isomers. 
1H NMR (400 MHz, CDCl3) δ 4.56 (q, 0.12 H, J = 6.9 Hz, C=CH E isomer), 4.46 (qt, J = 6.5, 1.0 Hz, 
C=CH Z isomer), 2.16-2.07 (m, 2.2 H, CH2 Z+E isomers), 1.64-1.59 (m, 3 H, CHCH3 Z isomer), 1.57-
1.54 (d, 0.4 H, J = 6.8 Hz, E isomer), 1.25-1.02 (m, 27 H, TIPS + CH2CH3 Z+E isomers). 
13C NMR (101 MHz, CDCl3) (only Z isomer) δ 153.2, 99.4, 29.4, 18.1, 13.3, 11.8, 10.7.  
The characterization data for 5n corresponded to the reported values13 
 
(Cyclohex-1-en-1-yloxy)triisopropylsilane (5o): 
 
 
 
Using method A, starting from 474 mg of cyclohexanone (4.82 mmol), 1.22 g (4.82 mmol, 100 % 
yield) of a colorless oil were obtained. 
1H NMR (400 MHz, CDCl3) δ 4.88 (m, 1 H, C=CH), 2.11-1.99 (m, 4 H, -CH2-), 1.72-1.64 (m, 2 H, -
CH2-), 1.57-1.50 (m, 2 H, -CH2-), 1.22-1.04 (m, 21 H, TIPS) 
13C NMR (101 MHz, CDCl3) δ 150.6, 103.6, 30.0, 23.9, 23.3, 22.4, 18.0, 12.7. 
The characterization data for 5o corresponded to the reported values14 
 
  
                                                          
13 P. Magnus, L. Barth, Tetrahedron, 1995, 51, 11075 
14 J. Q. Yu, H. C. Wu, E. J. Corey, Org. Lett. 2005, 7, 1415 
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Scope of the Reaction 
Complete optimization table 
 
 
 
Acid Conversion % Closed/Open 
SnCl4 100.00a >100/1 
SnCl4 100.00 1/1 
Cu(OTf)2 100.00 5/1 
(CuOTf)2.Tol 100.00 1/1 
In(Otf)3 100.00 >1/100 
AlCl3 100.00 0.4/1 
Sn(Otf)2 100.00 2/1 
Yb(Otf)3 100.00 5/1 
HNTf2 100.00 >1/100 
Sc(Otf)3 100.00 1/3 
Hf(Otf)4 100.00 1/2 
Zn(NTf)2 100.00 1/2,5 
Zn(OTf)2 40.00 0.5/1 
Ni(ClO4)2 30.00 >10/1 
CuCl2 0 nd 
AgOTf 0 nd 
Me2AlCl 0 nd 
MgI2 0 nd 
H3PO4 0 nd 
Camphorsulfonic acid 0 nd 
Trifluoroacetic acid 0 nd 
BF3.OEt2 0 nd 
Bn2BOTf 0 nd 
a: reaction at -78 °C 
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General procedure for the SnCl4-catalyzed synthesis of N-phthalimide 
aminocyclopentane : 
 
In an oven-dried flask sealed with a septum and under N2 atmosphere is added the N-phthalimide 
aminocyclopropane (0.3 mmol, 1 eq) and the silyl-enol ether (1.5 eq) in dry dichloromethane (0.15 M). 
The solution is cooled down to -78 °C and a 0.43 M solution of tin tetrachloride (5 mol %) in dry 
dichloromethane is added. The reaction is stirred for 1 h at -78 °C. Triethylamine (0.2 mL) is then 
added in one portion at -78 °C. The reaction is warmed at room temperature and stirred for 15 min. 
Dichloromethane is removed under reduced pressure and the crude is directly purified by column 
chromatography (8:2 Hexane/Ethyl Acetate). 
 
Trans-Diethyl-4-(1,3-dioxoisoindolin-2-yl)-2-phenyl-2-((triisopropylsilyl)oxy)cyclopentane-1,1-
dicarboxylate (6da): 
 
 
 
Using the method described above, 180 mg (0.296 mmol, 98%) of a single diastereomer as a colorless 
solid was obtained.  
Rf 0.54 (7:3, Hexane/Ethyl acetate). 
Mp 113.4 °C.  
1H NMR (400 MHz, CDCl3) δ 7.90-7.81 (m, 4 H, Phth + Ar), 7.74 (m, 2 H, Phth), 7.33-7.26 (m, 3 H, 
Ar), 5.30 (m, 1 H, N-C-H), 4.33 (m, 2 H, CO2CH2), 4.00-3.81 (m, 3 H, CO2CH2+ CH2), 3.42 (ddd, 1 
H, J = 13.6, 9.5, 1.1 Hz, CH2), 2.89 (dd, 1 H, J = 13.7, 8.9 Hz, CH2), 2.46 (ddd, 1 H, J = 12.3, 6.0, 1.0 
Hz, CH2), 1.36 (t, 3H,  J = 7.1 Hz, CH3), 1.03-0.92 (m, 24 H, CH3 + TIPS) 
13C NMR (101 MHz, CDCl3) δ 170.6, 168.4, 168.3, 142.0, 134.0, 132.0, 128.6, 127.9, 127.1, 123.2, 
87.5, 70.1, 61.5, 61.0, 47.9, 41.8, 36.3, 18.2, 18.2, 13.715 
IR 2944 (w), 2868 (w), 2258 (w), 1775 (w), 1734 (m), 1712 (s), 1377 (s), 1253 (m), 1128 (s), 981 (m) 
HRMS (ESI) calcd for C34H46NO7Si+ [M+H]+ 608.3038; found 608.3050  
Recrystallized in ethanol.  
  
                                                          
15 The CH3 carbons of TIPS are splitting. 
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The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated 
the deposition number : CCDC 842232 
 
Trans-Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-phenyl-2-((triisopropylsilyl)oxy)cyclopentane-1,1-
dicarboxylate (6fa): 
 
 
 
Using the method described above, 165 mg (0.284 mmol, 95%) of a single diastereomer as a colorless 
solid was obtained. 
The two enantiomers were separated by HPLC using Chiralpack IA column (0.46x25 cm), 95:5 
Hexane/Isopropanol, 0.5 ml/min; tr1 = 20.0 min, [α]D25.0 - 40.3 (c = 1, CHCl3); tr2 = 21.4 min,  
Rf 0.55 (6:4, Hexane/Ethyl acetate). 
Mp 134.5 °C.  
1H NMR (400 MHz, CDCl3) δ 7.87 (m, 2H, Phth), 7.80-7.72 (m, 4 H, Phth + Ar), 7.34-7.25 (m, 3 H, 
Ar), 5.29 (m, 1 H, N-C-H), 3.86 (s, 3 H, OMe), 3.81 (t, 1 H, J = 12.2 Hz, CH2), 3.47-3.39 (m, 4 H, 
OMe + CH2), 2.91 (dd, 1 H, J = 13.7, 8.7 Hz, CH2), 2.46 (dd, 1 H, J = 12.4, 6.2 Hz, CH2), 1.01-0.92 
(m, 21 H, TIPS).  
13C NMR (101 MHz, CDCl3) δ 171.0, 168.7, 168.4, 141.8, 134.1, 132.0, 128.4, 128.0, 127.1, 123.2, 
87.6, 70.1, 52.4, 52.1, 47.8, 41.7, 36.2, 18.2, 18.2, 13.715 
IR 2952 (w), 2868 (w), 2259 (w), 1738 (m), 1712 (s), 1378 (m), 1129 (s), 981 (m).  
HRMS (ESI) calcd for C32H42NO7Si+ [M+H]+ 580.2725; found 580.2717.  
 
Trans-Dimethyl-2-((tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-
phenylcyclopentane-1,1-dicarboxylate (6fb):  
 
 
 
Using the method described above, 157 mg (0.293 mmol, 98%) of a single diastereomer as a colorless 
solid was obtained.  
Rf 0.38 (7:3, Hexane/Ethyl acetate). 
Mp 162.9 °C. 
1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, Phth), 7.79-7.68 (m, 4 H, Phth + Ar), 7.36-7.26 (m, 3 H, 
Ar), 5.27 (m, 1 H, N-C-H), 3.87 (s, 3 H, OMe), 3.78 (dd, 1 H, J = 12.2, 12.2 Hz, CH2), 3.47 (s, 3 H, 
OMe), 3.41 (ddd, 1 H, J = 13.5, 9.3, 1.2 Hz, CH2), 2.93 (dd, 1 H, J = 13.6, 8.9 Hz, CH2), 2.36 (dd, 1H, 
J = 12.0, 5.0 Hz, CH2), 0.95 (s, 9 H, TBS), 0.04 (s, 3 H, TBS), -0.47 (s, 3 H, TBS). 
13C NMR (101 MHz, CDCl3) δ 170.9, 168.7, 168.3, 141.3, 134.1, 132.0, 128.4, 127.9, 127.2, 123.2, 
87.1, 69.8, 52.4, 52.1, 47.7, 41.7, 36.2, 25.8, 18.5, -2.5, -3.5. 
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IR 2953 (w), 2932 (w), 2887 (w), 2857 (w), 2258 (w), 1737 (m), 1712 (s), 1378 (m), 1128 (m), 909 
(s). 
HRMS (ESI) calcd for C29H36NO7Si+ [M+Na]+ 560.2075; found 560.2012.  
 
Trans-Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-phenyl-2-((trimethylsilyl)oxy)cyclopentane-1,1-
dicarboxylate (6fc): 
 
 
 
Using the method described above, 141 mg (0.285 mmol, 95%) of a single diastereomer as a colorless 
solid was obtained. 
Rf 0.35 (7:3, Hexane/Ethyl acetate).  
Mp 139.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.87 (m, 2 H, Phth), 7.76 (m, 2 H, Phth), 7.69-7.65 (m, 2 H, Ar), 7.35-
7.27 (m, 3 H, Ar), 5.23 (m, 1 H, N-C-H), 3.85 (s, 3 H, OMe), 3.80 (t, 1 H, J = 12.2 Hz, CH2), 3.49 (s, 3 
H, OMe), 3.36 (ddd, 1 H, J = 13.5, 9.3, 1.4 Hz, CH2), 2.93 (dd, 1 H, J = 13.6, 9.0 Hz, CH2), 2.28 (ddd, 
1 H, J = 12.2, 5.9, 1.2 Hz, CH2), -0.03 (s, 9 H, TMS). 
13C NMR (101 MHz, CDCl3) δ 170.7, 168.9, 168.4, 141.3, 134.1, 132.0, 128.2, 127.8, 127.2, 123.2, 
87.2, 69.8, 52.2, 52.1, 47.9, 41.6, 35.8, 1.6. 
IR 2953 (w), 2924 (w), 2850 (w), 1773 (w), 1738 (s), 1712 (s), 1379 (m), 1253 (m), 1131 (m), 985 
(m), 845 (s). 
HRMS (ESI) calcd for C26H30NO7Si+ [M+H]+ 496.1786; found 496.1800 
 
Trans-Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-(4-fluorophenyl)-2-((triisopropylsilyl)oxy)cyclo-
pentane-1,1-dicarboxylate (6fd):  
 
 
 
Using the method described above, 163 mg (0.273 mmol, 91%) of a single diastereomer as a colorless 
solid was obtained.  
Rf 0.6 (6:4, Hexane/Ethyl acetate).  
Mp 152.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, Phth), 7.79-7.73 (m, 4 H, Phth + Ar), 7.00 (t, 2 H, J = 
8.7 Hz, Ar), 5.27 (m, 1 H, N-C-H), 3.86 (s, 3 H, OMe), 3.79 (dd, 1 H, J = 12.2, 12.2 Hz, CH2), 3.51 (s, 
3 H, OMe), 3.44 (ddd, 1 H, J = 13.8, 9.7, 0.9 Hz, CH2), 2.89 (dd, 1 H, J = 13.9, 8.4 Hz), CH2, 2.44 
(dd, 1 H, J = 12.5, 6.3 Hz, CH2), 1.03-0.93 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 170.9, 168.6, 168.3, 162.4 (d, J = 247 Hz), 137.7 (d, J = 4 Hz), 134.1, 
132.0, 130.4 (d, J = 8 Hz), 123.2, 113.9 (d, J = 21 Hz), 87.1, 70.0, 52.4, 52.3, 47.6, 41.9, 36.1, 18.2, 
18.1, 13.715 
IR 2951 (w), 2894 (w), 2869 (w), 1775 (w), 1739 (m), 1714 (s), 1514 (w), 1379 (m), 1129 (m) 
HRMS (ESI) calcd for C32H41FNO7Si [M+H]+ 598.2631; found 598.2708.  
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Trans-Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-(4-(methoxycarbonyl)phenyl)-2-((triisopropyl-
silyl)oxy) cyclopentane-1,1-dicarboxylate (6fe): 
 
 
 
Using the method described above, 181 mg (0.284 mmol, 95%) of a single diastereomer as a colorless 
solid was obtained.  
Rf 0.5 (6:4, Hexane/Ethyl acetate).  
Mp 151.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.99 (m, 2 H, Ar), 7.88-7.82 (m, 4 H, Ar + Phth), 7.75 (m, 2 H, Phth), 
5.28 (m, 1 H, N-C-H), 3.92 (s, 3 H, OMe), 3.85 (s, 3H, OMe), 3.81 (dd, 1 H, J = 12.4 Hz, CH2), 3.52-
3.42 (m, 4 H, OMe + CH2), 2.88 (dd, 1 H, J = 13.9, 8.1 Hz, CH2), 2.47 (dd, 1 H, J = 12.4, 6.2 Hz, 
CH2), 1.03-0.91 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 170.7, 168.5, 168.3, 166.9, 146.7, 134.1, 131.9, 129.5, 128.7, 128.3, 
123.3, 87.2, 70.0, 52.5, 52.3, 52.1, 47.4, 41.7, 36.1, 18.2, 18.1, 13.715 
IR 2953 (w), 2870 (w), 2256 (w), 1712 (m), 1283 (w), 908 (s), 731 (s) 
HRMS (ESI) calcd for C34H43NNaO9Si+ [M+Na]+ 660.2599; found 660.2604 
 
Trans-Dimethyl-2-(4-cyanophenyl)-4-(1,3-dioxoisoindolin-2-yl)-2-((triisopropylsilyl)oxy)cyclo-
pentane-1,1-dicarboxylate (6ff): 
 
 
 
Using the method described above, 127 mg (0.210 mmol, 70%) of a single diastereomer as a colorless 
solid was obtained. 
Rf 0.42 (6:4, Hexane/Ethyl acetate). 
Mp 116.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.93-7.84 (m, 4 H, Ar + Phth), 7.76 (m, 2 H, Phth), 7.63 (m, 2 H, Ar), 
5.27 (m, 1 H, N-C-H), 3.85 (s, 3 H, OMe), 3.77 (dd, 1 H, 12.2, 12.2 Hz, CH2), 3.55 (s, 3 H, OMe), 3.50 
(dd, 1 H, J = 14.1, 10.2 Hz, CH2), 2.86 (dd, 1 H, J = 14.1, 7.8 Hz, CH2), 2.46 (dd, 1 H, J = 12.5, 6.5 
Hz, CH2), 1.04-0.91 (m, 21 H, TIPS).  
13C NMR (101 MHz, CDCl3) δ 170.6, 168.3, 168.2, 146.9, 134.2, 131.9, 130.8, 129.5, 123.3, 118.9, 
111.8, 86.9, 69.9, 52.6, 52.5, 47.0, 41.5, 36.0, 18.2, 18.1, 13.815 
IR 2951 (w), 2869 (w), 2230 (w), 1739 (m), 1712 (s), 1380 (m), 1136 (m), 1124 (m), 983 (m), 912 
(m), 735 (s), 727 (s) 
HRMS (ESI) calcd for C33H40N2NaO7Si+ [M+Na]+ 627.2497; found 627.2499 
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Trans-Dimethyl 4-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)-2-((triisopropylsilyl)oxy)cyclo-
pentane-1,1-dicarboxylate (6fg): 
 
 
 
Using the method described above, 182 mg (0.298 mmol, 99%) of a single diastereomer as a colorless 
solid was obtained. 
Rf 0.48 (6:4, Hexane/Ethyl acetate). 
Mp 142.3 °C. 
1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, Phth), 7.74 (m, 2 H, Phth), 7.69 (d, J = 9.0 Hz, 2 H, Ar), 
6.83 (d, J = 9.0 Hz, 2 H, Ar), 5.27 (m, 1 H, N-C-H), 3.86 (s, 3 H, OMe), 3.83 (s, 3 H, OMe), 3.78 (dd, 
1 H,  J = 12.2, 12.2 Hz, CH2), 3.51 (s, 3 H, OMe), 3.42 (ddd, 1 H, J = 13.6, 9.7, 0.7 Hz, CH2), 2.89 
(dd, 1 H,  J = 13.8, 8.6 Hz, CH2), 2.43 (dd, 1 H,  J = 12.3, 6.2 Hz, CH2), 1.04-0.93 (m, 21 H, TIPS) 
13C NMR (101 MHz, CDCl3) δ 171.1, 168.8, 168.3, 159.1, 134.0, 133.99, 132.0, 129.7, 123.2, 112.3, 
87.4, 70.0, 55.2, 52.3, 52.2, 47.8, 41.9, 36.2, 18.2, 18.2, 13.715 
IR 2949 (w), 2868 (w), 1776 (w), 1737 (m), 1712 (s), 1378 (m), 1255 (m), 1125 (m), 981 (m), 722 (s). 
HRMS (ESI) calcd for C33H43NNaO8Si+ [M+Na]+ 632.2650; found 632.2651.  
 
Trans-Dimethyl-2-(2-bromophenyl)-4-(1,3-dioxoisoindolin-2-yl)-2-((triisopropylsilyl)oxy)cyclo-
pentane-1,1-dicarboxylate (6fh):  
 
 
 
Using the method described above, 183 mg (0.277 mmol, 92%) of a single diastereomer as a colorless 
solid was obtained. 
The two enantiomers were separated by HPLC using Chiralpack IC column (0.46x25 cm), 95:5 
Hexane/Isopropanol, 1 ml/min; tr1 = 20.9 min; tr2 = 24.9 min, [α]D25.0 – 43.0 (c = 1, CHCl3) 
Rf 0.46 (6:4, Hexane/Ethyl acetate). 
Mp 155.7 °C.  
1H NMR (400 MHz, CDCl3) δ 7.88-7.81 (m, 3 H, Phth +Ar), 7.71 (m, 2 H, Phth), 7.57 (dd, 1 H, J = 
8.0, 1.4 Hz, Ar), 7.24 (m, 1 H, Ar), 7.06 (m, 1 H, Ar), 5.22 (m, 1 H, N-C-H), 4.40 (dd, 1 H, J = 12.8, 
12.8 Hz, CH2), 3.79 (s, 3 H, OMe), 3.60 (s, 3 H, OMe), 3.35 (dd, 1 H, J = 13.5, 10.0 Hz, CH2), 2.78 
(dd, 1 H, J = 13.7, 7.4 Hz, CH2), 2.60 (dd, 1 H, J = 12.9, 6.0 Hz, CH2), 1.04-0.94 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 174.4, 172.0, 171.6, 143.1, 137.1, 135.8, 135.2, 133.7, 130.8, 127.3, 
124.6, 123.2, 89.0, 70.3, 50.4, 50.4, 45.7, 40.8, 33.5, 14.9, 14.7, 10.3.15 
IR 2949 (w), 2868 (w), 2259 (w), 2255 (w), 1774 (w), 1758 (m), 1737 (s), 1712 (s), 1378 (m), 913 
(m), 734 (s), 722 (s) 
HRMS (ESI) calcd for C3279BrH41NO7Si+ [M+H]+ 658.1830; found 658.1835 
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Trans- Dimethyl 4-(1,3-dioxoisoindolin-2-yl)-2-(naphthalen-2-yl)-2-((triisopropylsilyl)oxy)cyclo-
pentane-1,1-dicarboxylate (6fi):  
 
 
 
Using the method described above, 171 mg (0.272 mmol, 91%) of a single diastereomer as a colorless 
solid were obtained.  
Rf 0.6 (6:4, Hexane/Ethyl acetate) 
Mp 193.8 °C.  
1H NMR (400 MHz, CDCl3) δ 8.39 (d, 1 H, J = 8.4 Hz, Ar), 7.90-7.79 (m, 5 H, Phth+ Ar), 7.75 (m, 2 
H, Phth), 7.45 (t, 1 H, J = 7.8 Hz, Ar), 7.42-7.33 (m, 2 H, Ar), 5.42 (m, 1 H, N-C-H), 3.90 (dd, 1 H, J = 
12.5, 1.5 Hz, CH2), 3.76 (dd, 1 H, J = 14.3, 11.7 Hz, CH2), 3.63 (s, 3 H, OMe), 3.43 (s, 3 H, OMe), 
2.95 (dd, 1 H, J = 14.4, 4.7 Hz, CH2), 2.67 (dd, 1 H, J = 12.5, 7.3 Hz, CH2), 1.08-1.03 (m, 12 H, 
TIPS), 0.73-0.68 (m, 9 H, TIPS) 
13C NMR (101 MHz, CDCl3) δ 171.0, 169.8, 168.3, 136.4, 134.5, 134.0, 132.4, 132.0, 129.7, 128.8, 
128.5, 124.7, 124.0, 123.6, 123.3, 90.9, 68.6, 52.4, 52.2, 45.5, 43.7, 37.8, 18.5, 17.9, 14.315 
IR 3050 (w), 2949 (w), 2894 (w), 2868 (w), 2258 (w), 1775 (w), 1762 (w), 1734 (s), 1712 (s), 1378 
(m), 1123 (m), 970 (m), 910 (m), 732 (s). 
HRMS (ESI) calcd for C36H44NO7Si+ [M+H]+ 630.2882; found 630.2876.  
 
Dimethyl 4-(1,3-dioxoisoindolin-2-yl)-3-methyl-2-phenyl-2-((triisopropylsilyl)oxy)cyclo-pentane-
1,1-dicarboxylate  (6fj):  
 
 
 
Using the method described above, 164 mg (0.275 mmol, 92%) of two diastereomers (20:1) as a 
colorless solid was obtained. 
The two enantiomers were separated by HPLC using Chiralpack IA column (0.46x25 cm), 93:7 
Hexane/Isopropanol, 1 ml/min; tr1 = 7.5 min, [α]D25.0 48.4 (c = 1, CHCl3); tr2 = 12.8 min.  
Major diastereomer 
Rf 0.52 (6:4, Hexane/Ethyl acetate). 
Mp 120 °C. 
1H NMR (400 MHz, CDCl3) δ 7.84 (m, 2 H, Phth), 7.73 (m, 2 H, Phth), 7.69-7.65 (m, 2 H, Ar), 7.36-
7.27 (m, 3 H, Ar), 4.90 (td, 1 H, J = 11.1, 6.9 Hz, N-C-H), 3.99 (m, 1 H, CHCH3), 3.78 (s, 3 H, OMe), 
3.53 (s, 3 H, OMe), 3.45 (dd, 1 H, J = 14.3, 11.0 Hz, CH2), 2.72 (dd, J = 14.3, 6.9 Hz, 1 H, CH2), 1.25-
1.07 (m, 15 H, TIPS + Me), 0.99-0.95 (m, 9 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 170.8, 168.7, 168.5, 139.6, 134.0, 131.9, 129.6, 127.8, 126.7, 123.2, 
90.6, 70.1, 53.1, 52.3, 43.4, 34.1, 18.8, 18.7, 15.1, 11.915 
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IR 2950 (w), 2869 (w), 1758 (w), 1739 (s), 1739 (s), 1717 (s), 1381 (m), 1126 (m), 735 (m), 724 (s). 
HRMS (ESI) calcd for C33H43NNaO7Si+ [M+Na]+ 616.2701; found 616.2717. 
 
Dimethyl-3-(1,3-dioxoisoindolin-2-yl)-9b-((triisopropylsilyl)oxy)-3,3a,4,5-tetrahydro-1H-
cyclopenta[a]naphthalene-1,1(2H,9bH)-dicarboxylate (6fk):  
 
 
 
Using the method described above, 166 mg (0.274 mmol, 91%) of two diastereomers (10:1) as a 
colorless solid were obtained.  
The major diastereomer was recrystallized from isopropanol: 
Rf 0.50 (6:4, Hexane/Ethyl acetate). 
Mp 179.1 °C 
1H NMR (400 MHz, CDCl3) δ 8.20 (d, 1 H, J = 7.0 Hz, Ar), 7.88 (m, 2 H, Phth), 7.76 (m, 2 H, Phth), 
7.22 (dd, 1 H, J = 7.2, 7.2 Hz, Ar), 7.16 (dd, 1 H, J = 7.4, 7.0 Hz, Ar), 7.07 (d, 1 H, J = 7.6 Hz, Ar), 
5.17 (m, 1 H, N-C-H), 3.98 (dd, 1 H, J = 12.9, 12.9 Hz, CH2-C(CO2Me)2), 3.88 (s, 3 H, OMe), 3.32 
(m, 1 H, -CH-), 3.26 (s, 3 H, OMe), 3.04 (m, 1 H, , Ar-CH2), 2.63 (m, 1 H, Ar-CH2), 2.16 (dd, 1 H, J = 
12.6, 5.6 Hz, CH2-C(CO2Me)2), 1.87 (m, 1 H, Ar-CH2-CH2), 1.66 (m, 1 H, Ar-CH2-CH2), 1.10-0.87 
(m, 21 H, TIPS) 
13C NMR (101 MHz, CDCl3) δ 170.8, 168.5, 168.3, 140.2, 138.2, 134.1, 131.9, 129.2, 127.5, 127.3, 
126.1, 123.3, 83.4, 71.0, 52.5, 52.1, 50.3, 49.8, 34.3, 25.3, 21.2, 18.4, 18.0, 14.015 
IR 2950 (w), 2868 (w), 2256 (w), 1773 (w), 1715 (s), 1381 (m), 1128 (m), 908 (s), 731 (s) 
HRMS (ESI) calcd for C34H43NNaO7Si+ [M+Na]+ 628.2701; found 628.2722. 
 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated 
the deposition number : CCDC 842233 
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Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-2-phenyl-2-((triisopropylsilyl)oxy)cyclopen-
tane-1,1-dicarboxylate (6fl):  
 
 
 
Using the method described above, 147 mg (0.242 mmol, 81%) of two non-separable diastereomers 
(4:1) as a colorless solid were obtained. 
Rf 0.52 (6:4, Hexane/Ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.93 (m, 2 H, Ar, Isomer 1 & 2), 7.84 (m, 2.5 H, Phth, Isomer 1 & 2), 
7.79-7.72 (m, 3 H, Phth + Ar, Isomer 1 & 2), 7.51 (m, 0.5 H, Ar, Isomer 2), 7.34-7.24 (m, 4 H, Ar, 
Isomer 1 & 2), 5.12 (dd, 1 H, J = 13.0, 7.3 Hz, N-C-H, Isomer 1), 4.77 (m, 0.25 H, N-C-H, Isomer 2), 
4.48 (dd, 0.25 H, J = 13.4, 13.4 Hz, CH2, Isomer 2), 3.86 (s, 3 H, OMe, Isomer 1), 3.78 (s, 0.75 H, 
OMe, Isomer 2), 3.69-3.61 (m, 1.75 H, OMe, Isomer 2, CH2, Isomer 1), 3.55 (s, 3 H, OMe, Isomer 1), 
3.02 (dd, 1 H, J = 13.4, 7.4 Hz, CH2, Isomer 1), 2.40 (dd, 0.25 H, J = 13.3, 7.4 Hz, CH2, Isomer 2), 
1.52 (s, 3 H, Me, Isomer 1), 1.41 (s, 0.75 H, Me, Isomer 2), 1.31 (s, 3 H, Me, Isomer 1), 1.04 (s, 0.75 
H, Me, Isomer 2), 1.02-0.98 (m, 12 H, TIPS, Isomer 1 & 2), 0.97-0.92 (m, 10 H, TIPS, Isomer 1 & 2), 
0.90-0.80 (m, 4 H, TIPS, Isomer 1 & 2) 
13C NMR (101 MHz, CDCl3) δ 172.2, 170.2, 169.7, 169.3, 141.8, 141.4, 134.1, 134.0, 131.8, 129.5, 
128.5, 127.7, 127.4, 127.2, 126.9, 123.2, 93.3, 69.6, 58.8, 57.8, 53.3, 52.9, 52.7, 52.5, 52.4, 32.9, 32.5, 
29.0, 25.2, 23.6, 21.4, 19.0, 18.8, 18.8, 15.0, 14.615,16 
IR 2949 (w), 2869 (w), 1777 (w), 1735 (m), 1716 (s), 1373 (m), 1034 (m), 911 (m), 731 (s). 
HRMS (ESI) calcd for C34H46NO7Si+ [M+H]+ 608.3038; found 608.3010 
 
Trans-dimethyl 2-butyl-4-(1,3-dioxoisoindolin-2-yl)-2-((triisopropylsilyl)oxy)cyclopentane-1,1-
dicarboxylate (6fm): 
 
 
 
Using the method described above, 164 mg (0.293 mmol, 98%) of a colorless oil were obtained. 
A mixture of 4 diatereo- and regioisomers in the crude NMR with a ratio of 16.6:5:5:1 were identified 
by 2D NMR.  
Rf 0.25 (9:1, Hexane/Ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.88-7.80 (m, 3 H), 7.76-7.69 (m, 3 H), 5.34 (q, 0.1 H, J = 9.8 Hz ), 
5.12 (m, 1 H), 4.76 (m, 0.25 H), 4.46 (m, 0.06 H), 3.85-3.82 (m, 3.5 H), 3.80-3.74 (m, 4.6 H), 3.39 (t, 
0.05 H, J = 12.7 Hz), 3.38-3.26 (m, 1.30 H), 2.95 (dd, 1 H, J = 12.7, 11.3 Hz), 2.75 (m, 0.06 H), 2.64 
(dd, 1 H, J = 14.5, 7.0 Hz), 2.57-2.47 (m, 0.9 H), 2.47-2.40 (dd, 0.2 H, J = 14.6, 5.7 Hz), 2.10 (dd, 1 H, 
                                                          
16 not all the signals of the minor diastereoisomer were resolved by 13C. 
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J = 12.8, 7.3 Hz), 1.91 (m, 1 H), 1.57 (m, 0.3 H), 1.53-1.26 (m, 8 H), 1.06-1.21 (m, 30 H), 0.90 (t, 4 H, 
J = 7.3 Hz), 0.75 (t, 0.9 H, J = 7.2 Hz), 0.67 (t, 0.3 H, J = 7.3 Hz). 
13C NMR (101 MHz, CDCl3) δ 171.5, 169.3, 168.3, 133.9, 132.0, 123.2, 123.1, 88.6, 68.9, 52.5, 52.4, 
50.8, 47.4, 41.2, 36.6, 35.1, 34.6, 29.6, 28.1, 23.4, 22.3, 21.3, 18.6, 18.5, 18.4, 18.3, 14.4, 14.1, 13.9, 
13.815 
IR 2952 (w), 2895 (w), 2868 (w), 1776 (w), 1741 (s), 1714 (s), 1377 (m), 1129 (m). 
HRMS (ESI) calcd for C29H44NO7Si+ [M+H]+ 560.3038; found 560.3030 
 
Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-ethyl-3-methyl-2-((triisopropylsilyl)oxy)cyclopentane-
1,1-dicarboxylate (3fn): 
 
 
 
Using the method described above, 157 mg (0.288 mmol, 96%) of a colorless oil were obtained. 
Starting from a 1:8 mixture of Z:E silyl enol ether, a mixture of 3 diastereomer with a ratio of 11:4:1 
was identified by 2D NMR. 
Rf 0.7 (6:4, Hexane/Ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.88-7.81 (m, 2 H), 7.69-7.76 (m, 3 H), 4.86 -4.73 (m, 1 H), 4.55-4.43 
(m, 0 H), 3.81-3.69 (m, 8 H), 3.54-3.40 (m, 1 H), 3.39-3.31 (m, 1 H), 3.08 (dd, 1 H, J = 14.3, 10.6 Hz), 
2.72-2.58 (m, 2 H), 2.36-2.20 (m, 1 H), 1.99-1.88 (m, 1 H), 1.88-1.80 (m, 0 H), 1.23 (t, 1 H, J = 7.0 
Hz), 1.20-1.09 (m, 29 H), 1.09-0.96 (m, 9 H) 
13C NMR (101 MHz, CDCl3) δ 171.6, 171.3, 169.6, 169.5, 168.6, 168.3, 133.9, 132.0, 131.8, 123.2, 
123.1, 89.9, 87.8, 67.6, 67.2, 54.0, 52.6, 52.4, 52.4, 52.3, 48.5, 42.6, 35.1, 34.8, 30.5, 29.7, 29.4, 18.7, 
18.6, 18.5, 18.4, 18.0, 14.6, 14.1, 13.4, 13.3, 11.3, 9.9, 9.715 
IR 2951 (w), 2869 (w), 1737 (m), 1715 (s), 1378 (m), 1266 (w), 1249 (w), 1127 (m) 
HRMS (ESI) calcd for C29H44NO7Si+ [M+H]+ 546.2882; found 546.2870 
 
Dimethyl-3-(1,3-dioxoisoindolin-2-yl)-7a-((triisopropylsilyl)oxy)octahydro-1H-indene-1,1-
dicarboxylate (6fo):  
 
 
 
Using the method described above, 159 mg (0.285 mmol, 95%) of three diastereomers (14:3:1) as a 
colorless oil were obtained. The major diastereomer was separated from others by column 
chromatography.  
The two enantiomers were separated by HPLC using Chiralpack IB column (0.46x25 cm), 98:2 
Hexane/Isopropanol, 0.6 ml/min; tr1 = 20.0 min, [α]D25.0 20.1 (c = 0.5, CHCl3); tr2 = 24.4 min, Rf 0.70 
(6:4, Hexane/Ethyl acetate). 
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1H NMR (400 MHz, CDCl3) δ 7.82 (m, 2 H, Phth), 7.71 (m, 2 H, Phth), 5.25 (ddd, 1 H, J = 10.1, 
10.1, 7.1 Hz, N-C-H), 4.04 (dd, 1 H, J = 14.4, 10.5 Hz, CH2 cyclopentane), 3.78 (s, 3 H, OMe), 3.74 
(s, 3 H, OMe), 3.03 (dd, 1 H, J = 14.4, 9.8 Hz, CH2 cyclopentane), 2.91 (m, 1 H, CH2), 2.38 (m, 1 H, -
CH-), 1.80-1.54 (m, 4 H, CH2), 1.54-1.41 (m, 1 H, CH2), 1.39-1.28 (m, 1H, CH2), 1.23-1.09 (m, 22 H, 
TIPS + CH2) 
13C NMR (101 MHz, CDCl3) δ 170.2, 169.3, 169.2, 133.9, 131.9, 123.1, 87.1, 68.0, 52.8, 52.8, 52.6, 
52.5, 34.4, 29.9, 23.9, 23.3, 23.2, 18.4, 18.6, 13.715 
IR 2949 (w), 2867 (w), 1774 (w), 1739 (m), 1715 (s), 1373 (w), 1133 (w) 
HRMS (ESI) calcd for C30H44NO7Si+ [M+H]+ 558.2882; found 558.2892. 
 
Trans-Dimethyl-4-(1,3-dioxoisoindolin-2-yl)-2-((trimethylsilyl)oxy)cyclopentane-1,1-
dicarboxylate (6fp):  
 
 
 
Using the method described above, 97.0 mg (0.231 mmol, 77%) of a single diastereomer as a colorless 
solid was obtained. 
The two enantiomers were separated by HPLC using Chiralpack IA column (0.46x25 cm), 98:2 
Hexane/Isopropanol, 1 ml/min; tr1 = 19.8 min; tr2 = 24.0 min, [α]D25.0 - 51 (c = 0.68, CHCl3) 
Rf 0.40 (6:4, Hexane/Ethyl acetate). 
Mp 120.6 °C. 
1H NMR (400 MHz, CDCl3) δ 7.80 (m, 2 H, Phth), 7.69 (m, 2 H, Phth), 5.11 (m, 1 H, N-C-H), 4.99 
(dd, 1 H, J = 4.1, 1.8 Hz, O-C-H), 3.82 (s, 3 H, OMe), 3.72 (s, 3 H, OMe), 3.14 (dd, 1 H, J = 14.4, 10.7 
Hz, CH2), 2.55 (m, 1 H, CH2), 2.46 (dd, 1 H, J = 14.5, 6.6 Hz, CH2), 1.98 (ddd, 1 H, J = 12.9, 7.9, 1.9 
Hz, CH2), 0.11 (m, 9 H, TMS). 
13C NMR (101 MHz, CDCl3) δ 171.3, 169.0, 168.0, 134.0, 131.9, 123.2, 76.4, 66.0, 52.8, 52.5, 47.6, 
38.7, 33.8, 0.0. 
IR 2955 (w), 1775 (w), 1737 (s), 1710 (s), 1378 (m), 1251 (m), 1124 (m), 844 (s), 720 (s). 
HRMS (ESI) calcd for C20H26NO7Si+ [M+H]+ 420.1473; found 420.1483.  
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated 
the deposition number : CCDC 842234 
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Trans-dimethyl 2-butoxy-4-(1,3-dioxoisoindolin-2-yl)cyclopentane-1,1-dicarboxylate (6fq): 
 
 
 
Using the method described above, 119 mg (0.296 mmol, 99%) of two unseparable diastereomers 
(20:1) as colorless oil were obtained.  
Major diastereomer: 
Rf 0.5 (6:4 Hexane/Ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.84 (m, 2 H, Phth), 7.72 (m, 2 H, phth), 5.06 (m, 1 H, N-C-H), 4.64 
(dd, 1 H, J = 4.2, 2.1 Hz, -CH-O), 3.87 (s, 3 H, OMe), 3.77 (s, 3 H, OMe), 3.57 (dt, 1 H, J = 9.2, 6.1 
Hz, OCH2 n-butyl), 3.38 (dt, 1 H, J = 9.2, 6.5 Hz, OCH2 n-butyl), 3.14 (dd, 1 H, J = 14.5, 10.7 Hz, 
CH2-C(CO2Me)2), 2.54-2.42 (m, 2 H, CH2-CH-O-), 2.23 (ddd, 1 H, J = 13.2, 8.1, 2.1 Hz, CH2-
C(CO2Me)2), 1.59-1.45 (m, 2 H, CH2 n-butyl), 1.42-1.25 (m, 2 H, CH2 n-butyl), 0.92 (t, 4 H, J = 7.4 
Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 171.3, 169.0, 168.0, 134.0, 131.9, 123.2, 83.1, 69.6, 64.9, 52.9, 52.6, 
47.4, 34.8, 34.1, 31.8, 19.3, 13.9 
HRMS (ESI) calcd for C21H26NO7+ [M+H]+ 404.1704; found 404.1720. 
 
Dimethyl 5-(1,3-dioxoisoindolin-2-yl)hexahydrocyclopenta[b]pyran-7,7(7aH)dicarboxylate (6fr): 
 
 
Using the method described above, 115 mg (0.297 mmol, 99%) of two diastereomers (1.7:1) as a 
colorless solid was obtained. The two isomers were separated by column chromatography. 
6fr-trans 
Recrystallized in isopropanol  
Rf 0.13 (6:4, Hexane/Ethyl acetate).  
Mp 169.2 °C.  
1H NMR (400 MHz, CDCl3) δ 7.82 (m, 2 H, Phth), 7.72 (m, 2 H, Phth), 4.87 (m, 1 H, N-C-H), 4.29 
(d, 1 H, J = 11.8 Hz, O-C-H), 4.05 (dd, 1 H, J = 11.5, 4.5 Hz, CH2-O), 3.89 (s, 3 H, OMe), 3.79 (s, 3 
H, OMe), 3.51 (dd, 1 H, J = 12.1, 12.1, 3.0 Hz, CH2-O), 3.04 (dd, 1 H, J = 15.2, 9.6 Hz, CH2 
cyclopentane), 2.70 (dd, 1 H, J = 15.2, 2.7 Hz, CH2 cyclopentane), 2.25 (m, 1 H, CH cyclopentane), 
1.87 (m, 1 H, CH2 pyran), 1.68-1.49 (m, 2 H, CH2 pyran), 1.14 (qd, 1 H, J = 12.2, 4.3 Hz, CH2 pyran). 
13C NMR (101 MHz, CDCl3) δ 171.8, 171.0, 168.8, 134.2, 131.5, 123.4, 84.2, 69.2, 61.8, 53.1, 53.0, 
49.2, 45.0, 35.0, 25.2, 25.0 
IR 2951 (w), 2853 (w), 2255 (w), 1779 (w), 1749 (w), 1731 (m), 1708 (m), 1370 (m), 1276 (m), 723 
(s), 648 (s), 634 (s).  
HRMS (ESI) calcd for C20H22NO7+ [M+H]+ 388.1391; found 388.1404.  
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6fr trans 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated 
the deposition number : CCDC 842235 
 
6fr-cis 
Rf 0.31 (6:4, Hexane/Ethyl acetate). 
Mp 173.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.83 (m, 2 H, Phth), 7.72 (m, 2 H, Phth), 5.05 (ddd, 1 H, J = 10.9, 
10.9, 6.6 Hz, N-C-H), 4.47 (d, 1 H, J = 3.0 Hz, O-C-H), 4.00 (dd, 1 H, J = 11.4, 4.4 Hz, CH2-O), 3.88 
(s, 3 H, OMe), 3.77 (s, 3 H, OMe), 3.40 (dd, 1 H, J = 12.2, 2.1 Hz, CH2-O), 3.27 (dd, 1 H, J = 14.6, 
11.0 Hz, CH2 cyclopentane), 2.87 (m, 1 H, CH cyclopentane), 2.64 (dd, 1 H, J = 14.6, 6.5 Hz, CH2 
cyclopentane), 1.99 (m, 1 H, CH2 pyran), 1.74 (m, 1 H, CH2 pyran), 1.59 (m, 1 H, CH2 pyran), 1.40 
(m, 1 H, CH2 pyran). 
13C NMR (101 MHz, CDCl3) δ 171.0, 168.8, 168.2, 134.0, 131.9, 123.2, 82.1, 67.9, 63.9, 52.9, 52.9, 
49.0, 40.9, 33.0, 21.0, 20.0. 
IR 2954 (w), 2858 (w), 1736 (s), 1710 (s), 1383 (m), 1108 (m), 912 (m), 719 (s) 
HRMS (ESI) calcd for C20H22NO7+ [M+H]+ 388.1391; found 388.1395. 
 
Diethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-4-oxo-4-phenylbutyl)malonate (7da): 
 
 
 
Indium (III) trifluoromethanesulfonate (17.0 mg, 0.026 mmol, 20 mol %) is weighted in the glovebox. 
The flask is closed with a septum and put under N2 atmosphere. A solution of aminocyclopropane (50 
mg, 0.15 mmol, 1 eq) and silyl enol ether (50 mg, 0.18 mmol, 1.2 eq) in 1 mL of dry dichloromethane 
is added. The reaction is stirred overnight at room temperature. The reaction is filtered through a plug 
of silica in order to remove the catalyst and concentrated under reduced pressure. Purification by 
column chromatograpy (6:4 Hexane/Ethyl Acetate) furnished 58 mg (0.13 mmol, 85 % yield) of the 
desired product as a colorless oil. 
Rf 0.32 (6:4 Hexane/Ethyl Acetate). 
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1H NMR (400 MHz, CDCl3) δ 7.93 (m, 2 H, Ar), 7.87-7.80 (m, 2 H, Phth), 7.75-7.68 (m, 2 H, Phth), 
7.59-7.53 (m, 1 H, Ar), 7.48-7.41 (m, 2 H, Ar), 5.02-4.94 (m, 1 H, N-C-H), 4.29-4.20 (m, 2 H, 
CO2CH2CH3), 4.09-3.92 (m, 3 H, CO2CH2CH3 + CH(CO2Et)2), 3.51 (dd, 1 H, J = 17.7, 5.3 Hz, CH2-
CO-Ph), 3.40 (dd, 1 H, J = 8.3, 6.2 Hz, CH2-CO-Ph), 2.79 (ddd, 1 H, J = 14.3, 11.0, 6.2 Hz, CH2), 
2.47 (ddd, 1 H, J = 14.3, 8.3, 4.1 Hz, CH2), 1.29 (t, 3 H, J = 7.1 Hz, CO2CH2CH3), 1.17 (t, 3 H, J = 7.1 
Hz, CO2CH2CH3). 
13C NMR (101 MHz, CDCl3) δ 196.7, 168.7, 168.4, 168.2, 136.5, 134.0, 133.4, 131.8, 128.7, 128.1, 
123.3, 61.8, 61.6, 49.6, 45.6, 40.7, 31.6, 14.0, 13.9. 
IR 2983 (w), 1776 (w), 1748 (m), 1731 (s), 1711 (s), 1687 (w), 1393 (w), 1373 (m). 
HRMS (ESI) calcd for C25H26NO7+ [M+H]+ 452.1704; found 452.1708 
 
dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-3-methyl-4-oxo-4-phenylbutyl)malonate (7fj) : 
 
 
 
Following the same procedure described above, using 50 mg (0.17 mmol, 1 eq) of aminocyclopropane, 
72 mg (0.25 mmol, 1.5 eq) of silyl enol ether and 18.5 mg (0.033 mmol, 20 mol %) of Indium (III) 
trifluoromethanesulfonate, 49 mg (0.11 mmol, 67 % yield) of a colorless oil is obtained after column 
chromatography purification (9:1 Hexane/Ethyl Acetate to 8:2 Hexane/Ethyl Acetate).  
4:1 Mixture of syn/anti diastereomers: 
Rf 0.29 (6:4 Hexane/Ethyl Acetate). 
1H NMR (400 MHz, CDCl3) δ 8.00-8.04 (m, 2 H, Ar), 7.94-7.88 (m, 2 H, Phth), 7.88-7.85 (m, 0.5 H, 
Phth), 7.81-7.76 (m, 2 H, Phth), 7.76-7.72 (m, 0.5 H, Phth), 7.68-7.60 (m, 1.5 H, Ar), 7.57-7.46 (m, 
2.25 H, Ar), 7.42-7.35 (m, 0.5 H, Ar), 4.83 (dd, 1 H, J = 10.7, 3.2 Hz, N-C-H), 4.62 (m, 0.5 H, N-C-H 
+ Me-CH-CO-Ph), 4.48 (qd, 1 H, J = 10.4, 7.0 Hz, Me-CH-CO-Ph), 3.79 (s, 0.75 H, CO2CH3), 3.76 
(s, 3 H, CO2CH3), 3.56 (s, 0.75 H, CO2CH3), 3.46 (s, 3 H, CO2CH3), 3.41-3.33 (m, 1.25 H, 
CH(CO2Et)2), 2.76 (ddd, 1 H, J = 14.4, 11.4, 6.7 Hz, CH2), 2.72-2.59 (m, 0.5 H, CH2), 2.23 (ddd, 1 H, 
J = 14.4, 7.9, 3.2 Hz, CH2), 1.38 (d, 0.75 H, J = 6.8 Hz, CH3), 1.09 (d, 3 H, J = 7.1 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 201.8, 201.2, 169.2, 169.1, 168.8, 168.6, 168.5, 136.1, 135.9, 134.3, 
134.0, 133.6, 133.2, 131.5, 131.4, 128.9, 128.7, 128.6, 128.4, 123.5, 123.3, 53.0, 52.9, 52.7, 52.5, 
51.9, 51.4, 49.8, 48.9, 42.6, 42.3, 30.0, 28.9, 16.5, 16.0 
IR 2955 (w), 1753 (m), 1753 (m), 1736 (s), 1710 (s), 1680 (m), 1389 (m), 1367 (m), 723 (s). 
HRMS (ESI) calcd for C24H24NO7+ [M+H]+ 438.1547; found 438.1556 
 
 
 
Indium (III) trifluoromethanesulfonate (5 mg, 0.009 mmol, 20 mol %) is weighted in the glovebox. 
The flask is closed with a septum and put under N2 atmosphere. A solution of 6fj (26 mg, 0.044 mmol, 
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1 eq) in 0.5 mL of dry dichloromethane is added. The reaction is stirred overnight at room 
temperature. The reaction is filtered through a plug of silica in order to remove the catalyst and 
concentrated under reduced pressure. Purification by column chromatograpy (6:4 Hexane/Ethyl 
Acetate) furnished 15 mg (0.043 mmol, 78 % yield) of the desired product as a colorless oil. 
dr >20:1 syn/anti 
Rf 0.29 (6:4 Hexane/Ethyl Acetate). 
1H NMR (400 MHz, CDCl3) δ 8.07 (d, 2 H, J = 7.4 Hz, Ar), 7.91 (m, 2 H, Phth), 7.79 (m, 2 H, Phth), 
7.64 (m, 1 H, Ar), 7.54 (t, 2 H, J = 7.8 Hz, Ar), 4.84 (ddd, 1 H, J = 10.9, 10.9, 3.1 Hz, N-C-H), 4.48 
(m, 1 H, Me-CH-CO-Ph), 3.76 (s, 3 H, CO2CH3), 3.47 (s, 3 H, CO2CH3), 3.39 (dd, 1 H, J = 7.2, 7.2 
Hz, CH(CO2Et)2), 2.77 (ddd, 1 H, J = 14.4, 11.4, 6.8 Hz, CH2), 2.24 (ddd, 1 H, J = 14.4, 7.9, 3.2 Hz, 
CH2), 1.10 (d, 3 H, J = 7.1 Hz, , CH3) 
13C NMR (101 MHz, CDCl3) δ 201.2, 169.1, 168.6, 168.4, 136.1, 134.3, 133.6, 131.5, 128.9, 128.6, 
123.5, 52.8, 52.5, 51.9, 49.8, 42.3, 30.0, 16.0 
IR 2955 (w), 1754 (m), 1736 (s), 1712 (s), 1388 (m), 1368 (m), 723 (s) 
HRMS (ESI) calcd for C24H24NO7+ [M+H]+ 438.1547; found 438.1505. 
 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-4-oxo-4-phenylbutyl)malonate (7fa) : 
 
 
 
To a solution of aminocyclopropane (50 mg, 0.17 mmol, 1 eq) and silyl enol ether (68 mg, 0,25 mmol, 
1.5 eq) in 1 mL of dry dichloromethane under nitrogen, is added 19.2 µl (0.00826 mmol, 5 mol %) of 
a tin tetrachloride solution (0.43 M) at room temperature. The reaction is stirred one hour at room 
temperature after what 0.1 mL of triethylamine is added. The solution is concentrated under reduced 
pressure and purified by column chromatography (9:1 to 8:2 Hexane/Ethyl Acetate). 69 mg (0.12 
mmol, 72 %) of 3a and 16.4 (0.04 mmol, 24 %) of 7fa are isolated. 
 
7fa 
The two enantiomers were separated by HPLC using Chiralpack IA column (0.46x25 cm), 75:25 
Hexane/Isopropanol, 1 ml/min;,  
 
- 72.8 % ee  tr1 = 26.5 min [α]D25.0 - 27.3 (c = 1, CHCl3); tr2 = 28.2 min. 
+ 98 % ee  tr1 = 26.5 min; tr2 = 28.2 min. [α]D25.0 + 41 (c = 0.6, CHCl3); 
 
Sticky oil, 
Rf 0.45 (6:4 Hexane/Ethyl Acetate). 
1H NMR (400 MHz, CDCl3) δ 7.96-7.90 (m, 2 H, Ar), 7.87-7.81 (m, 2 H, Phth), 7.76-7.70 (m, 2 H, 
Phth), 7.59-7.54 (m, 1 H, Ar), 7.49-7.43 (m, 2 H, Ar), 5.02-4.92 (m, 1 H, N-C-H), 4.02 (dd, 1 H, J = 
17.9, 8.7 Hz, CH(CO2Et)2), 3.80 (s, 3 H, CO2CH3), 3.57 (s, 3 H, CO2CH3), 3.51 (dd, 1 H, J = 17.8, 5.3 
Hz, CH2-CO-Ph), 3.45 (dd, 1 H, J = 8.5, 6.1 Hz, CH2-CO-Ph), 2.80 (ddd, 1 H, J = 14.3, 11.2, 6.1 Hz, 
CH2), 2.48 (ddd, 1 H, J = 14.3, 8.6, 3.9 Hz, CH2). 
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13C NMR (101 MHz, CDCl3) δ 196.7, 169.1, 168.8, 168.2, 136.4, 134.1, 133.5, 131.7, 128.7, 128.1, 
123.4, 52.9, 52.7, 49.2, 45.5, 40.7, 31.7. 
IR 2956 (w), 1774 (w), 1753 (m), 1734 (s), 1709 (s), 1687 (w), 1373 (m), 1372 (m), 724 (m). 
HRMS (ESI) calcd for C23H22NO7+ [M+H]+ 424.1391; found 424.1386 
 
Trans-dimethyl 4-amino-2-phenyl-2-((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate (8) : 
 
 
 
Following a modified procedure17, 100 mg of 3a (0.172 mmol, 1 eq) is added in an oven dried flask 
with 52 mg (0.86 mmol, 5 eq) of ethylenediamine. Isopropanol is added and the white suspension is 
refluxed. After a few minutes, the starting material is completely solubilized and the reaction is heated 
during 8 h. The solvent is then removed under reduced pressure and the crude oil is purified by 
column chromatography (9:1 Ethyl Acetate/Hexane + 1% NEt3). 55 mg (0.12 mmol, 72 %) of a 
colorless oil corresponding to the free cyclopentylamine is isolated. 
Rf 0.2 (100 % Ethyl Acetate) 
Mp 200 °C decomposition 
1H NMR (400 MHz, CDCl3) δ 7.78-7.74 (m, 2 H, Ar), 7.32-7.24 (m, 3 H, Ar), 3.82-3.82 (m, 1 H, N-
C-H), 3.77 (s, 3 H, CO2CH3), 3.31 (s, 3 H, CO2CH3), 3.17 (dd, 1 H, J = 13.9, 8.7 H, CH2), 2.73 (dd, 1 
H, J = 13.5, 9.3 Hz, CH2), 2.61 (dd, 1 H, J = 13.4, 6.9 Hz, CH2), 1.99 (dd, 1 H, J = 14.0, 6.2 Hz, CH2), 
1.76 (br s, 2 H, NH2), 0.98-0.91 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 172.1, 169.2, 142.0, 128.0, 127.8, 127.2, 89.0, 71.3, 52.1, 49.4, 49.0, 
44.6, 29.7, 18.2, 13.8 
IR 2949 (w), 2949 (w), 2949 (w), 2949 (w), 2868 (w), 1752 (s), 1736 (s), 1717 (s), 1448 (w), 1263 
(m), 1106 (s), 1077 (s) 
HRMS (ESI) calcd for C24H40NO5Si+ [M+H]+ 450.2670; found 450.2660 
 
Dimethyl 4-(1,3-dioxoisoindolin-2-yl)-2-phenylcyclopent-2-ene-1,1-dicarboxylate (9) : 
 
 
 
3a (80 mg, 0.14 mmol, 1 eq) is added in an oven dried flask, under nitrogen. 1 mL of dry 
dichloromethane is added and the solution is cooled to 0 °C with an ice/water bath. TMSOTf (28 µl, 
0.15 mmol, 1.1 eq) is added and the reaction is stirred for 10 minutes at 0 °C. The solvent is 
evaporated under reduced pressure and the crude is purified by column chromatography (8:2 
Hexane/Ethyl Acetate). 30 mg of a colorless solid (0.074 mmol, 53 % yield) is isolated. 
                                                          
17 O. Kanie, S. C. Crawley, M. M. Palcic, O. Hindsgaul, Carbohydrate Research 1993, 243, 139 
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Rf 0.43 (6:4 Hexane/Ethyl Acetate). 
Mp 132 °C. 
1H NMR (400 MHz, CDCl3) δ 7.90-7.83 (m, 2 H, Phth), 7.79-7.72 (m, 2 H, Phth), 7.51-7.46 (m, 2 H, 
Ar), 7.37-7.29 (m, 3 H, Ar), 6.25 (d, 1 H, J = 2.3 Hz, C=CH), 5.65-5.58 (m, 1 H, N-C-H), 3.82 (s, 3 H, 
CO2CH3), 3.72 (s, 3 H, CO2CH3), 3.15 (m, 2 H, CH2). 
13C NMR (101 MHz, CDCl3) δ 171.6, 170.5, 167.9, 143.9, 134.6, 134.1, 131.9, 131.3, 128.0, 128.0, 
127.7, 123.4, 53.5, 53.1, 52.8, 40.3, 29.7. 
IR 1773 (w), 1732 (m), 1715 (s), 1391 (w), 1368 (w), 1273 (w), 1124 (w), 720 (m). 
HRMS (ESI) calcd for C23H20NO6+ [M+H]+ 406.1285; found 406.1295 
 
Methyl 4-(1,3-dioxoisoindolin-2-yl)-2-phenylcyclopent-1-enecarboxylate (10) : 
 
 
 
Following a modified procedure18, 3a (90 mg, 0.15 mmol, 1 eq) is dissolved is 2 mL 
dimethylsulfoxide and 5 µl (0.3 mmol, 2 eq) of water. The solution is stirred for 6 h at 170 °C. After 
cooling to room temperature, the reaction mixture is extracted three times with 5 mL of diethyl ether, 
washed three times with 5 mL of water, three times with 5mL brine dried over magnesium sulfate and 
filtered through a cotton plug. The solvents are evaporated under reduced pressure and the crude is 
purified by column chromatography (8:2 Hexane/Ethyl Acetate). 47 mg (0.14 mmol, 88 % yield) of a 
white solid is isolated 
Rf 0.51 (6:4 Hexane/Ethyl Acetate). 
Mp 165 °C. 
1H NMR19 (400 MHz, CDCl3) δ 7.88 (m, 2 H, Phth), 7.75 (m, 2 H, Phth), 7.31-7.44 (m, 5 H, Ar), 5.14 
(m, 1 H, N-C-H), 3.66 (s, 3 H, CO2CH3), 3.50 (m, 1 H, CH2), 3.35 (m, 1 H, CH2), 3.19 (m, 2 H, CH2) 
13C NMR19 (101 MHz, CDCl3) δ 171.5, 168.6, 154.4, 138.0, 135.9, 133.7, 129.8, 129.4, 129.3, 128.1, 
124.6, 49.3, 44.5, 41.3, 36.5 
IR 2949 (w), 1773 (w), 1710 (s), 1393 (m), 1378 (m), 1236 (m), 722 (m). 
HRMS (ESI) calcd for C21H17NNaO4+ [M+Na]+ 370.1050; found 370.1063 
 
  
                                                          
18 A. P. Krapcho, J. F. Weimaster, J. M. Eldridge, E. G. E. Jahngen Jr., A. J. Lovey, W. P. Stephens, J. Org. 
Chem., 1978, 43, 138 
19 Peaks are splitting due to conformers of methyl ester. 
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Enantiospecific Reactions 
 
General procedure for enantiospecific cycloaddition : 
In an oven-dried flask sealed with a septum and under N2 atmosphere is added the chiral N-
phthalimide aminocyclopropane (16 mg – 26 mg, 0.053 – 0.062 mmol, 1 eq) and the silyl-enol ether 
(1.5 eq) in dry dichloromethane (0.15 M). The solution is cooled down to -78 °C and a 0.43 M solution 
of tin tetrachloride (10 mol %) in dry dichloromethane is added. The reaction is stirred for 1 h at -78 
°C. Triethylamine (0.1 mL) is then added in one portion at -78 °C. The reaction is warmed at room 
temperature and stirred for 15 min. Dichloromethane is removed under reduced pressure and the crude 
is directly purified by column chromatography (8:2 Hexane/Ethyl Acetate). 
 
 
 
Entry %ee 4f 5 6 Yield %a dra %ee 6 
5 + 97.4 5a 6fa 82 > 20:1 98 
1 + 98.6 5h 6fh 73 > 20:1 81 
2 - 94.8 5j 6fj 76 3:1 94 
3 + 98.9 5o 6fo 77.5 3:1:1 99.2:99.1:98.9 
4 - 97.6 5p 6fp 74 > 20:1 95.7 
[a] Due to the small scale for these experiments, product of retroaldol was detected, affecting the yield and dr. 
 
Indium catalysed synthesis of enantioenriched Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)-4-oxo-4-
phenylbutyl)malonate (7fa): 
 
Indium (III) trifluoromethanesulfonate (3.3 mg, 0.018 mmol, 20 mol %) is weighted in the glovebox. 
The flask is closed with a septum and put under N2 atmosphere. A solution of aminocyclopropane (18 
mg, 0.059 mmol, 1 eq) and silyl enol ether (20 mg, 0.071 mmol, 1.2 eq) in dry dichloromethane (0.15 
M) is added. The reaction is stirred overnight at room temperature. The reaction is filtered through a 
plug of silica in order to remove the catalyst and concentrated under reduced pressure. Purification by 
column chromatograpy (6:4 Hexane/Ethyl Acetate) furnished 24 mg (0.058 mmol, 94 % yield) of the 
desired product as a colorless oil. 
 
 
 
%ee 4f Yield %a %ee 7fa 
- 94 94 - 72.8 
34 
 
Opening of enantioenriched cyclopentylamines: 
 
Indium (III) trifluoromethanesulfonate (3.5 mg, 0.0062 mmol, 20 mol %) is weighted in the glovebox. 
The flask is closed with a septum and put under N2 atmosphere. A solution of 6fa (18.1 mg, 0.031 
mmol, 1 eq) in 0.3 mL of dry dichloromethane (0.15 M) is added. The reaction is stirred overnight at 
room temperature. The reaction is filtered through a plug of silica in order to remove the catalyst and 
concentrated under reduced pressure. Purification by column chromatography (6:4 Hexane/Ethyl 
Acetate) furnished 7.2 mg (0.017 mmol, 55 % yield) of the desired product as a colorless oil. 
 
 
%ee 6fa Yield %a %ee 7fa 
98 55 98 
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Control Experiments 
 
 
To a solution of aminocyclopropane (30 mg, 0.098 mmol, 1 eq) and silyl enol ether (41 mg, 0.15 
mmol, 1.5 eq) in 0.3 mL of dry dichloromethane under nitrogen, is added 5.0 µl (0.019 mmol, 20 mol 
%) of a 4M HCl in dioxane solution at room temperature. The reaction is stirred at room temperature 
for 12 hours and no evolution of the starting material could be observed. 
 
 
 
In an oven-dried flask sealed with a septum and under N2 atmosphere is added 50 mg of N-
phthalimide aminocyclopropane (0.16 mmol, 1 eq), 68 mg of silyl-enol ether (0.25 mmol, 1.5 eq) and 
3.1 mg of 2,6-Di-tert-butylpyridine (0.016 mmol, 10 mol%) in 0.5 mL of dry dichloromethane. The 
solution is cooled down to -78 °C and 19.2 µL of a 0.43 M solution of tin tetrachloride (5 mol %) in 
dry dichloromethane is added. The reaction is stirred for 1 h at -78 °C. Triethylamine (0.1 mL) is then 
added in one portion at -78 °C. The reaction is warmed at room temperature and stirred for 15 min. 
Dichloromethane is removed under reduced pressure and the crude is analyzed by 1H NMR.  
Ratio of starting material/product = 2.5:1 
 
Spectra of New Compounds 
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